Companies:
11,396
total market cap:
S$189.284 T
Sign In
๐บ๐ธ
EN
English
$ SGD
$
USD
๐บ๐ธ
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
๐ป๐ณ Vietnam
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
ETFs
๐ All ETFs
๐๏ธ Bond ETFs
๏ผ Dividend ETFs
โฟ Bitcoin ETFs
โข Ethereum ETFs
๐ช Crypto Currency ETFs
๐ฅ Gold ETFs & ETCs
๐ฅ Silver ETFs & ETCs
๐ข๏ธ Oil ETFs & ETCs
๐ฝ Commodities ETFs & ETNs
๐ Emerging Markets ETFs
๐ Small-Cap ETFs
๐ Low volatility ETFs
๐ Inverse/Bear ETFs
โฌ๏ธ Leveraged ETFs
๐ Global/World ETFs
๐บ๐ธ USA ETFs
๐บ๐ธ S&P 500 ETFs
๐บ๐ธ Dow Jones ETFs
๐ช๐บ Europe ETFs
๐จ๐ณ China ETFs
๐ฏ๐ต Japan ETFs
๐ฎ๐ณ India ETFs
๐ฌ๐ง UK ETFs
๐ฉ๐ช Germany ETFs
๐ซ๐ท France ETFs
โ๏ธ Mining ETFs
โ๏ธ Gold Mining ETFs
โ๏ธ Silver Mining ETFs
๐งฌ Biotech ETFs
๐ฉโ๐ป Tech ETFs
๐ Real Estate ETFs
โ๏ธ Healthcare ETFs
โก Energy ETFs
๐ Renewable Energy ETFs
๐ก๏ธ Insurance ETFs
๐ฐ Water ETFs
๐ด Food & Beverage ETFs
๐ฑ Socially Responsible ETFs
๐ฃ๏ธ Infrastructure ETFs
๐ก Innovation ETFs
๐ Semiconductors ETFs
๐ Aerospace & Defense ETFs
๐ Cybersecurity ETFs
๐ฆพ Artificial Intelligence ETFs
Watchlist
Account
Quantum Corporation
QMCO
#7277
Rank
S$0.73 B
Marketcap
๐บ๐ธ
United States
Country
S$18.65
Share price
2.48%
Change (1 day)
94.24%
Change (1 year)
๐ฅ๏ธ Internet
๐ฉโ๐ป Tech
Categories
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
EPS
Stock Splits
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports (10-K)
ESG Reports
Quantum Corporation
Quarterly Reports (10-Q)
Financial Year FY2027 Q2
Quantum Corporation - 10-Q quarterly report FY2027 Q2
Text size:
Small
Medium
Large
QUANTUM CORP /DE/
0000709283
3/31
2027
Q2
FALSE
http://fasb.org/us-gaap/2026#OtherLiabilitiesCurrent
http://fasb.org/us-gaap/2026#OtherLiabilitiesCurrent
http://fasb.org/us-gaap/2026#OtherLiabilitiesCurrent
http://fasb.org/us-gaap/2026#OtherLiabilitiesCurrent
1
1
202
202
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
qtm:segment
0000709283
2026-04-01
2026-09-30
0000709283
2026-11-05
0000709283
2026-09-30
0000709283
2026-03-31
0000709283
us-gaap:ProductMember
2026-07-01
2026-09-30
0000709283
us-gaap:ProductMember
2025-07-01
2025-09-30
0000709283
us-gaap:ProductMember
2026-04-01
2026-09-30
0000709283
us-gaap:ProductMember
2025-04-01
2025-09-30
0000709283
qtm:ServiceAndSubscriptionsMember
2026-07-01
2026-09-30
0000709283
qtm:ServiceAndSubscriptionsMember
2025-07-01
2025-09-30
0000709283
qtm:ServiceAndSubscriptionsMember
2026-04-01
2026-09-30
0000709283
qtm:ServiceAndSubscriptionsMember
2025-04-01
2025-09-30
0000709283
us-gaap:RoyaltyMember
2026-07-01
2026-09-30
0000709283
us-gaap:RoyaltyMember
2025-07-01
2025-09-30
0000709283
us-gaap:RoyaltyMember
2026-04-01
2026-09-30
0000709283
us-gaap:RoyaltyMember
2025-04-01
2025-09-30
0000709283
2026-07-01
2026-09-30
0000709283
2025-07-01
2025-09-30
0000709283
2025-04-01
2025-09-30
0000709283
2025-03-31
0000709283
2025-09-30
0000709283
us-gaap:CommonStockMember
2025-06-30
0000709283
us-gaap:AdditionalPaidInCapitalMember
2025-06-30
0000709283
us-gaap:RetainedEarningsMember
2025-06-30
0000709283
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-06-30
0000709283
2025-06-30
0000709283
us-gaap:RetainedEarningsMember
2025-07-01
2025-09-30
0000709283
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-07-01
2025-09-30
0000709283
us-gaap:CommonStockMember
2025-07-01
2025-09-30
0000709283
us-gaap:AdditionalPaidInCapitalMember
2025-07-01
2025-09-30
0000709283
us-gaap:CommonStockMember
2025-09-30
0000709283
us-gaap:AdditionalPaidInCapitalMember
2025-09-30
0000709283
us-gaap:RetainedEarningsMember
2025-09-30
0000709283
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-09-30
0000709283
us-gaap:CommonStockMember
2026-06-30
0000709283
us-gaap:AdditionalPaidInCapitalMember
2026-06-30
0000709283
us-gaap:RetainedEarningsMember
2026-06-30
0000709283
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-06-30
0000709283
2026-06-30
0000709283
us-gaap:RetainedEarningsMember
2026-07-01
2026-09-30
0000709283
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-07-01
2026-09-30
0000709283
us-gaap:AdditionalPaidInCapitalMember
2026-07-01
2026-09-30
0000709283
us-gaap:CommonStockMember
2026-07-01
2026-09-30
0000709283
us-gaap:CommonStockMember
2026-09-30
0000709283
us-gaap:AdditionalPaidInCapitalMember
2026-09-30
0000709283
us-gaap:RetainedEarningsMember
2026-09-30
0000709283
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-09-30
0000709283
us-gaap:CommonStockMember
2025-03-31
0000709283
us-gaap:AdditionalPaidInCapitalMember
2025-03-31
0000709283
us-gaap:RetainedEarningsMember
2025-03-31
0000709283
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-03-31
0000709283
us-gaap:RetainedEarningsMember
2025-04-01
2025-09-30
0000709283
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-04-01
2025-09-30
0000709283
us-gaap:CommonStockMember
2025-04-01
2025-09-30
0000709283
us-gaap:AdditionalPaidInCapitalMember
2025-04-01
2025-09-30
0000709283
us-gaap:CommonStockMember
2026-03-31
0000709283
us-gaap:AdditionalPaidInCapitalMember
2026-03-31
0000709283
us-gaap:RetainedEarningsMember
2026-03-31
0000709283
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-03-31
0000709283
us-gaap:RetainedEarningsMember
2026-04-01
2026-09-30
0000709283
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-04-01
2026-09-30
0000709283
us-gaap:CommonStockMember
2026-04-01
2026-09-30
0000709283
us-gaap:AdditionalPaidInCapitalMember
2026-04-01
2026-09-30
0000709283
us-gaap:ServiceMember
2026-09-30
0000709283
qtm:SubscriptionRevenueMember
2026-09-30
0000709283
us-gaap:ProductMember
2026-09-30
0000709283
2025-04-01
2026-03-31
0000709283
us-gaap:SecuredDebtMember
qtm:TermLoanMember
2026-09-30
0000709283
us-gaap:SecuredDebtMember
qtm:TermLoanMember
2026-03-31
0000709283
us-gaap:ConvertibleDebtMember
2025-09-23
0000709283
qtm:ForbearanceWarrantsMember
2025-09-23
0000709283
us-gaap:ConvertibleDebtMember
2026-06-04
2026-06-04
0000709283
us-gaap:ConvertibleDebtMember
2026-06-04
0000709283
us-gaap:LineOfCreditMember
qtm:AmendedRevolvingCreditAgreementWithPNCMember
2026-06-04
2026-06-04
0000709283
us-gaap:EmployeeSeveranceMember
2025-03-31
0000709283
us-gaap:EmployeeSeveranceMember
2025-04-01
2025-09-30
0000709283
us-gaap:EmployeeSeveranceMember
2025-09-30
0000709283
us-gaap:EmployeeSeveranceMember
2026-03-31
0000709283
us-gaap:EmployeeSeveranceMember
2026-04-01
2026-09-30
0000709283
us-gaap:EmployeeSeveranceMember
2026-09-30
0000709283
us-gaap:EmployeeStockOptionMember
2026-04-01
2026-04-01
0000709283
us-gaap:EmployeeStockOptionMember
2026-08-01
2026-08-01
0000709283
us-gaap:EmployeeStockOptionMember
2026-09-01
2026-09-01
0000709283
us-gaap:EmployeeStockOptionMember
2025-07-01
2025-09-30
0000709283
us-gaap:EmployeeStockOptionMember
2025-04-01
2025-09-30
0000709283
us-gaap:CostOfGoodsAndServicesSold
2026-07-01
2026-09-30
0000709283
us-gaap:CostOfGoodsAndServicesSold
2025-07-01
2025-09-30
0000709283
us-gaap:CostOfGoodsAndServicesSold
2026-04-01
2026-09-30
0000709283
us-gaap:CostOfGoodsAndServicesSold
2025-04-01
2025-09-30
0000709283
us-gaap:ResearchAndDevelopmentExpense
2026-07-01
2026-09-30
0000709283
us-gaap:ResearchAndDevelopmentExpense
2025-07-01
2025-09-30
0000709283
us-gaap:ResearchAndDevelopmentExpense
2026-04-01
2026-09-30
0000709283
us-gaap:ResearchAndDevelopmentExpense
2025-04-01
2025-09-30
0000709283
us-gaap:SellingAndMarketingExpense
2026-07-01
2026-09-30
0000709283
us-gaap:SellingAndMarketingExpense
2025-07-01
2025-09-30
0000709283
us-gaap:SellingAndMarketingExpense
2026-04-01
2026-09-30
0000709283
us-gaap:SellingAndMarketingExpense
2025-04-01
2025-09-30
0000709283
us-gaap:GeneralAndAdministrativeExpense
2026-07-01
2026-09-30
0000709283
us-gaap:GeneralAndAdministrativeExpense
2025-07-01
2025-09-30
0000709283
us-gaap:GeneralAndAdministrativeExpense
2026-04-01
2026-09-30
0000709283
us-gaap:GeneralAndAdministrativeExpense
2025-04-01
2025-09-30
0000709283
us-gaap:RestrictedStockUnitsRSUMember
2026-07-01
2026-09-30
0000709283
us-gaap:RestrictedStockUnitsRSUMember
2025-07-01
2025-09-30
0000709283
us-gaap:RestrictedStockUnitsRSUMember
2026-04-01
2026-09-30
0000709283
us-gaap:RestrictedStockUnitsRSUMember
2025-04-01
2025-09-30
0000709283
us-gaap:PerformanceSharesMember
2026-07-01
2026-09-30
0000709283
us-gaap:PerformanceSharesMember
2025-07-01
2025-09-30
0000709283
us-gaap:PerformanceSharesMember
2026-04-01
2026-09-30
0000709283
us-gaap:PerformanceSharesMember
2025-04-01
2025-09-30
0000709283
us-gaap:EmployeeStockOptionMember
2026-07-01
2026-09-30
0000709283
us-gaap:EmployeeStockOptionMember
2026-04-01
2026-09-30
0000709283
us-gaap:PrivatePlacementMember
2026-06-04
2026-06-04
0000709283
us-gaap:PrivatePlacementMember
2026-06-04
0000709283
qtm:StandbyEquityPurchaseAgreementMember
2025-01-25
2025-01-25
0000709283
qtm:StandbyEquityPurchaseAgreementMember
2026-07-01
2026-09-30
0000709283
us-gaap:StockCompensationPlanMember
2026-07-01
2026-09-30
0000709283
us-gaap:StockCompensationPlanMember
2025-07-01
2025-09-30
0000709283
us-gaap:StockCompensationPlanMember
2026-04-01
2026-09-30
0000709283
us-gaap:StockCompensationPlanMember
2025-04-01
2025-09-30
0000709283
us-gaap:WarrantMember
2026-07-01
2026-09-30
0000709283
us-gaap:WarrantMember
2025-07-01
2025-09-30
0000709283
us-gaap:WarrantMember
2026-04-01
2026-09-30
0000709283
us-gaap:WarrantMember
2025-04-01
2025-09-30
0000709283
us-gaap:EmployeeStockOptionMember
2026-07-01
2026-09-30
0000709283
us-gaap:RestrictedStockUnitsRSUMember
2026-04-01
2026-09-30
0000709283
us-gaap:RestrictedStockUnitsRSUMember
2025-04-01
2025-09-30
0000709283
us-gaap:OtherAssetsNoncurrent
2026-09-30
0000709283
us-gaap:OtherLiabilitiesNoncurrent
2026-09-30
0000709283
us-gaap:CarryingReportedAmountFairValueDisclosureMember
qtm:TermLoanMember
us-gaap:FairValueInputsLevel2Member
2026-09-30
0000709283
us-gaap:EstimateOfFairValueFairValueDisclosureMember
qtm:TermLoanMember
us-gaap:FairValueInputsLevel2Member
2026-09-30
0000709283
us-gaap:CarryingReportedAmountFairValueDisclosureMember
qtm:TermLoanMember
us-gaap:FairValueInputsLevel2Member
2026-03-31
0000709283
us-gaap:EstimateOfFairValueFairValueDisclosureMember
qtm:TermLoanMember
us-gaap:FairValueInputsLevel2Member
2026-03-31
0000709283
qtm:ForbearanceWarrantsMember
2026-09-30
0000709283
qtm:ForbearanceWarrantsMember
2026-03-31
0000709283
qtm:ForbearanceWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MinimumMember
2026-09-30
0000709283
qtm:ForbearanceWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MaximumMember
2026-09-30
0000709283
qtm:ForbearanceWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MinimumMember
2026-03-31
0000709283
qtm:ForbearanceWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MaximumMember
2026-03-31
0000709283
qtm:ForbearanceWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2026-09-30
0000709283
qtm:ForbearanceWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2026-03-31
0000709283
qtm:ForbearanceWarrantsMember
us-gaap:MeasurementInputSharePriceMember
2026-09-30
0000709283
qtm:ForbearanceWarrantsMember
us-gaap:MeasurementInputSharePriceMember
2026-03-31
0000709283
qtm:ForbearanceWarrantsMember
qtm:MeasurementInputProbabilityMember
srt:WeightedAverageMember
2026-09-30
0000709283
qtm:ForbearanceWarrantsMember
qtm:MeasurementInputProbabilityMember
srt:MinimumMember
2026-09-30
0000709283
qtm:ForbearanceWarrantsMember
qtm:MeasurementInputProbabilityMember
srt:MaximumMember
2026-09-30
0000709283
qtm:ForbearanceWarrantsMember
qtm:MeasurementInputProbabilityMember
srt:WeightedAverageMember
2026-03-31
0000709283
qtm:ForbearanceWarrantsMember
qtm:MeasurementInputProbabilityMember
srt:MinimumMember
2026-03-31
0000709283
qtm:ForbearanceWarrantsMember
qtm:MeasurementInputProbabilityMember
srt:MaximumMember
2026-03-31
0000709283
us-gaap:EstimateOfFairValueFairValueDisclosureMember
qtm:ForbearanceWarrantsMember
2026-09-30
0000709283
us-gaap:EstimateOfFairValueFairValueDisclosureMember
qtm:ForbearanceWarrantsMember
2026-03-31
0000709283
qtm:ForbearanceWarrantsMember
2026-04-01
2026-06-30
0000709283
qtm:ForbearanceWarrantsMember
2026-06-30
0000709283
qtm:ForbearanceWarrantsMember
2026-07-01
2026-09-30
0000709283
qtm:ConversionWarrantsMember
2026-06-01
0000709283
qtm:ConversionWarrantsMember
2026-09-30
0000709283
qtm:ConversionWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MinimumMember
2026-09-30
0000709283
qtm:ConversionWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MaximumMember
2026-09-30
0000709283
qtm:ConversionWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MinimumMember
2026-06-01
0000709283
qtm:ConversionWarrantsMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MaximumMember
2026-06-01
0000709283
qtm:ConversionWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2026-09-30
0000709283
qtm:ConversionWarrantsMember
us-gaap:MeasurementInputPriceVolatilityMember
2026-06-01
0000709283
qtm:ConversionWarrantsMember
us-gaap:MeasurementInputSharePriceMember
2026-09-30
0000709283
qtm:ConversionWarrantsMember
us-gaap:MeasurementInputSharePriceMember
2026-06-01
0000709283
qtm:ConversionWarrantsMember
qtm:MeasurementInputProbabilityMember
srt:WeightedAverageMember
2026-09-30
0000709283
qtm:ConversionWarrantsMember
qtm:MeasurementInputProbabilityMember
srt:MinimumMember
2026-09-30
0000709283
us-gaap:ScenarioPlanMember
qtm:ConversionWarrantsMember
qtm:MeasurementInputProbabilityMember
2026-09-30
0000709283
qtm:ConversionWarrantsMember
qtm:MeasurementInputProbabilityMember
srt:WeightedAverageMember
2026-06-01
0000709283
qtm:ConversionWarrantsMember
qtm:MeasurementInputProbabilityMember
srt:MinimumMember
2026-06-01
0000709283
qtm:ConversionWarrantsMember
qtm:MeasurementInputProbabilityMember
srt:MaximumMember
2026-06-01
0000709283
us-gaap:EstimateOfFairValueFairValueDisclosureMember
qtm:ConversionWarrantsMember
2026-09-30
0000709283
us-gaap:EstimateOfFairValueFairValueDisclosureMember
qtm:ConversionWarrantsMember
2026-06-01
0000709283
qtm:ConversionWarrantsMember
2026-03-31
0000709283
qtm:ConversionWarrantsMember
2026-04-01
2026-06-30
0000709283
qtm:ConversionWarrantsMember
2026-07-01
2026-09-30
0000709283
us-gaap:ConvertibleDebtMember
qtm:DialecticMember
2026-06-04
2026-06-04
0000709283
us-gaap:ConvertibleDebtMember
qtm:DialecticMember
2026-04-01
2026-09-30
0000709283
us-gaap:ConvertibleDebtMember
qtm:DialecticMember
2026-06-04
0000709283
us-gaap:ConvertibleDebtMember
2026-03-31
0000709283
us-gaap:ConvertibleDebtMember
2026-04-01
2026-09-30
0000709283
us-gaap:ConvertibleDebtMember
2026-09-30
0000709283
srt:AmericasMember
us-gaap:ProductMember
2026-07-01
2026-09-30
0000709283
srt:AmericasMember
us-gaap:ProductMember
2025-07-01
2025-09-30
0000709283
srt:AmericasMember
us-gaap:ProductMember
2026-04-01
2026-09-30
0000709283
srt:AmericasMember
us-gaap:ProductMember
2025-04-01
2025-09-30
0000709283
srt:AmericasMember
qtm:ServiceAndSubscriptionsMember
2026-07-01
2026-09-30
0000709283
srt:AmericasMember
qtm:ServiceAndSubscriptionsMember
2025-07-01
2025-09-30
0000709283
srt:AmericasMember
qtm:ServiceAndSubscriptionsMember
2026-04-01
2026-09-30
0000709283
srt:AmericasMember
qtm:ServiceAndSubscriptionsMember
2025-04-01
2025-09-30
0000709283
srt:AmericasMember
2026-07-01
2026-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
srt:AmericasMember
2026-07-01
2026-09-30
0000709283
srt:AmericasMember
2025-07-01
2025-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
srt:AmericasMember
2025-07-01
2025-09-30
0000709283
srt:AmericasMember
2026-04-01
2026-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
srt:AmericasMember
2026-04-01
2026-09-30
0000709283
srt:AmericasMember
2025-04-01
2025-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
srt:AmericasMember
2025-04-01
2025-09-30
0000709283
srt:EuropeMember
us-gaap:ProductMember
2026-07-01
2026-09-30
0000709283
srt:EuropeMember
us-gaap:ProductMember
2025-07-01
2025-09-30
0000709283
srt:EuropeMember
us-gaap:ProductMember
2026-04-01
2026-09-30
0000709283
srt:EuropeMember
us-gaap:ProductMember
2025-04-01
2025-09-30
0000709283
srt:EuropeMember
qtm:ServiceAndSubscriptionsMember
2026-07-01
2026-09-30
0000709283
srt:EuropeMember
qtm:ServiceAndSubscriptionsMember
2025-07-01
2025-09-30
0000709283
srt:EuropeMember
qtm:ServiceAndSubscriptionsMember
2026-04-01
2026-09-30
0000709283
srt:EuropeMember
qtm:ServiceAndSubscriptionsMember
2025-04-01
2025-09-30
0000709283
srt:EuropeMember
2026-07-01
2026-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
srt:EuropeMember
2026-07-01
2026-09-30
0000709283
srt:EuropeMember
2025-07-01
2025-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
srt:EuropeMember
2025-07-01
2025-09-30
0000709283
srt:EuropeMember
2026-04-01
2026-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
srt:EuropeMember
2026-04-01
2026-09-30
0000709283
srt:EuropeMember
2025-04-01
2025-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
srt:EuropeMember
2025-04-01
2025-09-30
0000709283
srt:AsiaPacificMember
us-gaap:ProductMember
2026-07-01
2026-09-30
0000709283
srt:AsiaPacificMember
us-gaap:ProductMember
2025-07-01
2025-09-30
0000709283
srt:AsiaPacificMember
us-gaap:ProductMember
2026-04-01
2026-09-30
0000709283
srt:AsiaPacificMember
us-gaap:ProductMember
2025-04-01
2025-09-30
0000709283
srt:AsiaPacificMember
qtm:ServiceAndSubscriptionsMember
2026-07-01
2026-09-30
0000709283
srt:AsiaPacificMember
qtm:ServiceAndSubscriptionsMember
2025-07-01
2025-09-30
0000709283
srt:AsiaPacificMember
qtm:ServiceAndSubscriptionsMember
2026-04-01
2026-09-30
0000709283
srt:AsiaPacificMember
qtm:ServiceAndSubscriptionsMember
2025-04-01
2025-09-30
0000709283
srt:AsiaPacificMember
2026-07-01
2026-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
srt:AsiaPacificMember
2026-07-01
2026-09-30
0000709283
srt:AsiaPacificMember
2025-07-01
2025-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
srt:AsiaPacificMember
2025-07-01
2025-09-30
0000709283
srt:AsiaPacificMember
2026-04-01
2026-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
srt:AsiaPacificMember
2026-04-01
2026-09-30
0000709283
srt:AsiaPacificMember
2025-04-01
2025-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
srt:AsiaPacificMember
2025-04-01
2025-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
us-gaap:RoyaltyMember
2026-07-01
2026-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
us-gaap:RoyaltyMember
2025-07-01
2025-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
us-gaap:RoyaltyMember
2026-04-01
2026-09-30
0000709283
us-gaap:GeographicConcentrationRiskMember
us-gaap:SalesRevenueNetMember
us-gaap:RoyaltyMember
2025-04-01
2025-09-30
0000709283
qtm:PrimaryStorageSystemsMember
2026-07-01
2026-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
qtm:PrimaryStorageSystemsMember
2026-07-01
2026-09-30
0000709283
qtm:PrimaryStorageSystemsMember
2025-07-01
2025-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
qtm:PrimaryStorageSystemsMember
2025-07-01
2025-09-30
0000709283
qtm:PrimaryStorageSystemsMember
2026-04-01
2026-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
qtm:PrimaryStorageSystemsMember
2026-04-01
2026-09-30
0000709283
qtm:PrimaryStorageSystemsMember
2025-04-01
2025-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
qtm:PrimaryStorageSystemsMember
2025-04-01
2025-09-30
0000709283
qtm:SecondaryStorageSystemsMember
2026-07-01
2026-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
qtm:SecondaryStorageSystemsMember
2026-07-01
2026-09-30
0000709283
qtm:SecondaryStorageSystemsMember
2025-07-01
2025-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
qtm:SecondaryStorageSystemsMember
2025-07-01
2025-09-30
0000709283
qtm:SecondaryStorageSystemsMember
2026-04-01
2026-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
qtm:SecondaryStorageSystemsMember
2026-04-01
2026-09-30
0000709283
qtm:SecondaryStorageSystemsMember
2025-04-01
2025-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
qtm:SecondaryStorageSystemsMember
2025-04-01
2025-09-30
0000709283
qtm:DeviceandMediaMember
2026-07-01
2026-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
qtm:DeviceandMediaMember
2026-07-01
2026-09-30
0000709283
qtm:DeviceandMediaMember
2025-07-01
2025-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
qtm:DeviceandMediaMember
2025-07-01
2025-09-30
0000709283
qtm:DeviceandMediaMember
2026-04-01
2026-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
qtm:DeviceandMediaMember
2026-04-01
2026-09-30
0000709283
qtm:DeviceandMediaMember
2025-04-01
2025-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
qtm:DeviceandMediaMember
2025-04-01
2025-09-30
0000709283
us-gaap:ServiceMember
2026-07-01
2026-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
us-gaap:ServiceMember
2026-07-01
2026-09-30
0000709283
us-gaap:ServiceMember
2025-07-01
2025-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
us-gaap:ServiceMember
2025-07-01
2025-09-30
0000709283
us-gaap:ServiceMember
2026-04-01
2026-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
us-gaap:ServiceMember
2026-04-01
2026-09-30
0000709283
us-gaap:ServiceMember
2025-04-01
2025-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
us-gaap:ServiceMember
2025-04-01
2025-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
us-gaap:RoyaltyMember
2026-07-01
2026-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
us-gaap:RoyaltyMember
2025-07-01
2025-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
us-gaap:RoyaltyMember
2026-04-01
2026-09-30
0000709283
us-gaap:ProductConcentrationRiskMember
us-gaap:SalesRevenueNetMember
us-gaap:RoyaltyMember
2025-04-01
2025-09-30
0000709283
qtm:SubscriptionsMember
2026-04-01
2026-09-30
0000709283
qtm:SubscriptionsMember
2025-04-01
2025-09-30
0000709283
qtm:SubscriptionsMember
2026-07-01
2026-09-30
0000709283
qtm:SubscriptionsMember
2025-07-01
2025-09-30
0000709283
qtm:YueZhouEmilyWhiteMember
2026-07-01
2026-09-30
0000709283
qtm:YueZhouEmilyWhiteMember
2026-09-30
0000709283
qtm:JohnR.TracyMember
2026-07-01
2026-09-30
0000709283
qtm:JohnR.TracyMember
2026-09-30
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-Q
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
September 30, 2026
or
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___ to ___
Commission File Number
001-13449
Quantum Corporation
(Exact name of registrant as specified in its charter)
Delaware
94-2665054
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
10770 E. Briarwood Avenue
Centennial
CO
80112
(Address of Principal Executive Offices)
(Zip Code)
(408)
944-4000
Registrant's telephone number, including area code
(Former name, former address, and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common Stock, $0.01 par value per share
QMCO
Nasdaq Global Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
☒
Yes
¨
No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
☒
Yes
¨
No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
o
Accelerated filer
☒
Non-accelerated filer
o
Smaller reporting company
☒
Emerging growth company
o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
o
Yes
☒
No
As of November 05, 2026, there were
39,557,393
shares of Quantum Corporation’s common stock issued and outstanding.
Table of Contents
QUANTUM CORPORATION
QUARTERLY REPORT ON FORM 10-Q
For the Quarter Ended September 30, 2026
Table of Contents
Page
Number
Note Regarding Forward-Looking Statements
4
PART I
Item 1.
Financial Statements (unaudited):
Condensed Consolidated Balance Sheets
5
Condensed Consolidated Statements of Operations
and Comprehensive Loss
6
Condensed Consolidated Statements of Cash Flows
7
Condensed Consolidated Statements of Stockholders' Deficit
8
Index to Notes to Condensed Consolidated Financial Statements
10
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
26
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
35
Item 4.
Controls and Procedures
35
PART II
Item 1.
Legal Proceedings
37
Item 1A.
Risk Factors
37
Item 5.
Other Information
37
Item 6.
Exhibits
37
Signatures
39
3
Table of Contents
Note Regarding Forward-Looking Statements
As used in this Quarterly Report on Form 10-Q (this "Quarterly Report"), the terms the "Company," "Quantum," "we," "us," and "our" refer to Quantum Corporation and its subsidiaries taken as a whole, unless otherwise noted or unless the context indicates otherwise.
This report contains forward-looking statements. All statements contained in this report other than statements of historical fact, including, but not limited to, statements regarding our future operating results, financial position and liquidity, including the sufficiency of our capital resources; our business strategy, focus and plans; our market growth and trends; our products, services and expected benefits thereof; and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “could,” “would,” “project,” “plan,” “potentially,” “preliminary,” “likely,” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including the competitive pressures that we face; risks associated with executing our strategy; the impact of macroeconomic and geopolitical trends and events; the need to manage third-party suppliers and the distribution of our products and the delivery of our services effectively; the protection of our intellectual property assets, including intellectual property licensed from third parties; risks associated with our international operations; the development and transition of new products and services and the enhancement of existing products and services to meet customer needs; our response to emerging technological trends; the execution and performance of contracts by us and our suppliers, customers, clients and partners; the hiring and retention of key employees; risks associated with business combination and investment transactions; the outcome of any claims and disputes; our ability to generate sufficient cash flows and to obtain additional financing on acceptable terms, if at all; our ability to remediate the material weaknesses in our internal control over financial reporting and to maintain effective internal control over financial reporting following remediation; risks related to changes in our management; and those risks described under Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2026 and in our subsequent filings with the SEC. Moreover, we operate in a competitive and changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the effect of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the future events and trends discussed in this report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Accordingly, you should not rely on forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, performance, or events and circumstances reflected in the forward-looking statements will be achieved or occur. We undertake no obligation to update any of these forward-looking statements for any reason after the date of this report or to conform these statements to actual results or revised expectations.
4
Table of Contents
PART I—FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
QUANTUM CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts, unaudited)
September 30, 2026
March 31, 2026
Assets
Current assets:
Cash and cash equivalents
$
67,416
$
15,572
Restricted cash
79
662
Accounts receivable, net of allowance for credit losses of $
3,733
and $
3,234
, respectively
70,725
69,650
Inventories, net
21,907
16,103
Prepaid expenses
4,739
2,431
Other current assets
8,279
8,068
Total current assets
173,145
112,486
Property and equipment, net
8,675
9,284
Goodwill
12,969
12,969
Right-of-use assets, net
7,075
7,416
Other long-term assets
13,336
14,737
Total assets
$
215,200
$
156,892
Liabilities and Stockholders’ Deficit
Current liabilities:
Accounts payable
$
36,419
$
29,342
Accrued compensation
11,100
12,428
Deferred revenue, current portion
75,156
75,654
Term debt
—
54,811
Warrant liabilities
83,255
14,105
Other current liabilities
18,651
19,457
Total current liabilities
224,581
205,797
Deferred revenue, net of current portion
42,300
39,030
Convertible note
—
90,034
Operating lease liabilities
7,799
8,172
Other long-term liabilities
12,734
12,716
Total liabilities
287,414
355,749
Commitments and contingencies (Note 10)
Stockholders’ deficit
Preferred stock:
Preferred stock,
20,000
shares authorized;
no
shares issued as of September 30, 2026 and March 31, 2026, respectively
—
—
Common stock:
Common stock, $
0.01
par value;
225,000
shares authorized;
39,541
and
14,638
shares issued and outstanding at September 30, 2026 and March 31, 2026, respectively
395
146
Additional paid-in capital
1,172,297
853,974
Accumulated deficit
(
1,243,660
)
(
1,043,517
)
Accumulated other comprehensive loss
(
1,246
)
(
9,460
)
Total stockholders' deficit
(
72,214
)
(
198,857
)
Total liabilities and stockholders' deficit
$
215,200
$
156,892
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
Table of Contents
QUANTUM CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(in thousands, except per share amounts, unaudited)
Three Months Ended September 30,
Six Months Ended September 30,
2026
2025
2026
2025
Revenue
Product
$
62,584
$
35,368
$
116,456
$
72,905
Service and subscription
25,011
25,620
49,680
50,563
Royalty
2,030
1,727
4,293
3,534
Total revenue
89,625
62,715
170,429
127,002
Cost of revenue
Product
42,137
28,748
81,861
59,493
Service and subscription
10,762
10,415
20,122
21,243
Total cost of revenue
52,899
39,163
101,983
80,736
Gross profit
36,726
23,552
68,446
46,266
Operating expenses
Sales and marketing
12,168
11,819
23,196
24,474
General and administrative
11,126
11,006
20,734
24,576
Research and development
6,360
5,692
12,383
12,353
Restructuring charges
292
3,193
315
5,616
Total operating expenses
29,946
31,710
56,628
67,019
Income (loss) from operations
6,780
(
8,158
)
11,818
(
20,753
)
Other income (expense), net
80
(
185
)
292
(
616
)
Interest expense
—
(
6,227
)
(
2,097
)
(
12,743
)
Change in fair value of warrant liabilities
(
51,565
)
1,525
(
67,870
)
1,525
Change in fair value of convertible note
—
—
(
129,715
)
—
Loss on debt extinguishment, net
—
(
33,254
)
(
11,716
)
(
30,695
)
Loss before income taxes
(
44,705
)
(
46,299
)
(
199,288
)
(
63,282
)
Income tax provision
145
157
855
380
Net loss
$
(
44,850
)
$
(
46,456
)
$
(
200,143
)
$
(
63,662
)
Net loss per share - basic and diluted
$
(
1.14
)
$
(
3.49
)
$
(
6.51
)
$
(
5.65
)
Weighted average shares - basic and diluted
39,438
13,322
30,760
11,266
Net loss
$
(
44,850
)
$
(
46,456
)
$
(
200,143
)
$
(
63,662
)
Reclassification of loss on convertible note to loss on debt extinguishment
—
—
8,444
—
Foreign currency translation adjustments, net
(
154
)
(
62
)
(
230
)
660
Total comprehensive loss
$
(
45,004
)
$
(
46,518
)
$
(
191,929
)
$
(
63,002
)
The accompanying notes are an integral part of these condensed consolidated financial statements.
6
Table of Contents
QUANTUM CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
Six Months Ended September 30,
2026
2025
Operating activities
Net loss
$
(
200,143
)
$
(
63,662
)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization
2,311
1,857
Amortization of debt issuance costs
530
3,998
Non-cash lease expense
514
697
Paid-in-kind interest
924
3,579
Provision for manufacturing and service inventories
713
3,633
Stock-based compensation
1,583
(
205
)
Warrants issued in connection with debt amendments
1,280
25,420
Change in fair value of warrant liabilities
67,870
(
1,525
)
Change in fair value of convertible note
129,715
—
Non-cash loss on debt extinguishment
8,372
5,275
Other non-cash
289
1,936
Changes in assets and liabilities:
Accounts receivable
(
1,613
)
8,429
Inventories
(
6,517
)
(
150
)
Accounts payable
6,986
(
7,794
)
Prepaid expenses
(
2,309
)
(
1,786
)
Operating lease liabilities
(
464
)
(
587
)
Deferred revenue
2,773
(
12,021
)
Accrued restructuring charges
(
537
)
69
Accrued compensation
(
791
)
(
393
)
Other assets
220
2,162
Other liabilities
2,610
(
1,421
)
Net cash provided by (used in) operating activities
14,316
(
32,489
)
Investing activities
Purchases of property and equipment
(
643
)
(
1,606
)
Net cash used in investing activities
(
643
)
(
1,606
)
Financing activities
Borrowings of long-term debt, net of debt issuance costs
—
(
6,317
)
Repayment of long-term debt, net
(
56,830
)
(
909
)
Borrowings of credit facility
—
71,625
Repayments of credit facility and payment of amendment fees
—
(
98,682
)
Proceeds from shares related to the SEPA, net
—
66,993
Proceeds from issuance of common stock, net
143
81
Proceeds from shares issued related to private placement, net
94,275
—
Net cash provided by financing activities
37,588
32,791
Effect of exchange rate changes on cash and cash equivalents
—
30
Net change in cash, cash equivalents, and restricted cash
51,261
(
1,274
)
Cash, cash equivalents, and restricted cash at beginning of period
16,234
16,603
Cash, cash equivalents, and restricted cash at end of period
$
67,495
$
15,329
Supplemental disclosure of cash flow information
Cash paid for interest
$
—
$
4,591
Cash paid for income taxes, net of refunds
$
379
$
327
Non-cash investing and financing transactions:
Purchases of property and equipment included in accounts payable
$
190
$
117
Right-of-use assets obtained in exchange for new lease liabilities
$
65
$
9
Warrants issued in connection with debt amendments
$
1,280
$
25,420
Common stock issued upon conversion of convertible note (
14,104,620
shares)
$
222,571
$
—
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows:
Cash and cash equivalents
$
67,416
$
14,670
Restricted cash
79
659
Total cash, cash equivalents and restricted cash at the end of period
$
67,495
$
15,329
The accompanying notes are an integral part of these condensed consolidated financial statements.
7
Table of Contents
QUANTUM CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT
(in thousands, unaudited)
Common Stock
Additional
Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total Stockholders' Deficit
Three Months Ended
Shares
Amount
Balance as of June 30, 2025
13,319
$
133
$
846,046
$
(
959,677
)
$
(
888
)
$
(
114,386
)
Net loss
—
—
—
(
46,456
)
—
(
46,456
)
Foreign currency translation adjustments, net of income taxes
—
—
—
—
(
62
)
(
62
)
Shares issued under employee incentive plans
14
—
81
—
—
81
Stock-based compensation
—
—
324
—
—
324
Balance, September 30, 2025
13,333
$
133
$
846,451
$
(
1,006,133
)
$
(
950
)
$
(
160,499
)
Balance, June 30, 2026
39,375
$
393
$
1,171,684
$
(
1,198,810
)
$
(
1,092
)
$
(
27,825
)
Net loss
—
—
—
(
44,850
)
—
(
44,850
)
Foreign currency translation adjustments, net of income taxes
—
—
—
—
(
154
)
(
154
)
Shares issued related to private placement, net
—
—
(
363
)
—
—
(
363
)
Shares issued under employee stock option plans
132
1
(
1
)
—
—
—
Shares issued under employee stock incentive plans
34
1
142
—
—
143
Stock-based compensation
—
—
835
—
—
835
Balance, September 30, 2026
39,541
$
395
$
1,172,297
$
(
1,243,660
)
$
(
1,246
)
$
(
72,214
)
QUANTUM CORPORATION
8
Table of Contents
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT
(in thousands, unaudited)
Common Stock
Additional
Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total Stockholders' Deficit
Six Months Ended
Shares
Amount
Balance, March 31, 2025
6,962
$
70
$
779,645
$
(
942,471
)
$
(
1,610
)
$
(
164,366
)
Net loss
—
—
—
(
63,662
)
—
(
63,662
)
Foreign currency translation adjustments
—
—
—
—
660
660
Shares issued under employee incentive plans
51
—
81
—
—
81
Shares issued related to the SEPA
6,320
63
66,930
—
—
66,993
Stock-based compensation
—
—
(
205
)
—
—
(
205
)
Balance, September 30, 2025
13,333
$
133
$
846,451
$
(
1,006,133
)
$
(
950
)
$
(
160,499
)
Balance, March 31, 2026
14,638
$
146
$
853,974
$
(
1,043,517
)
$
(
9,460
)
$
(
198,857
)
Net loss
—
—
—
(
200,143
)
—
(
200,143
)
Foreign currency translation adjustments
—
—
—
—
(
230
)
(
230
)
Change in fair value of convertible note
—
—
—
—
8,444
8,444
Shares issued related to private placement, net
10,616
106
94,169
—
—
94,275
Shares issued under employee stock option plans
132
1
(
1
)
—
—
—
Shares issued under employee incentive plans
50
1
142
—
—
143
Shares issued related to the convertible note
14,105
141
222,430
—
—
222,571
Stock-based compensation
—
—
1,583
—
—
1,583
Balance, September 30, 2026
39,541
$
395
$
1,172,297
$
(
1,243,660
)
$
(
1,246
)
$
(
72,214
)
The accompanying notes are an integral part of these condensed consolidated financial statements.
9
Table of Contents
INDEX TO NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Page
Note 1:
Description of Business and Significant Accounting Policies
11
Note 2:
Revenue
13
Note 3:
Balance Sheet Information
14
Note 4:
Debt
15
Note 5:
Leases
16
Note 6:
Restructuring Charges
17
Note 7:
Common Stock
17
Note 8:
Net Loss Per Share
18
Note 9:
Income Taxes
19
Note 10:
Commitments and Contingencies
19
Note 11:
Fair Value of Financial Instruments
21
Note 12:
Segment Information
23
10
Table of Contents
QUANTUM CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
NOTE 1: DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES
Description of Business
Quantum Corporation, together with its consolidated subsidiaries (“Quantum”, the “Company”, "our" or "we"), stores and manages digital video and other forms of unstructured data, providing streaming performance for video and rich media applications, along with low-cost, long-term storage systems for data protection and archiving. The Company helps customers around the world capture, create and share digital data and preserve and protect it for decades. The Company’s software-defined, hyperconverged storage solutions span from non-volatile memory express (“NVMe”), to solid state drives (“SSD”), hard disk drives (“HDD”), tape and the cloud and are tied together leveraging a single namespace view of the entire data environment. The Company works closely with a broad network of distributors, value-added resellers (“VARs”), direct marketing resellers (“DMRs”), original equipment manufacturers (“OEMs”) and other suppliers to meet customers’ evolving needs.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information. All intercompany balances and transactions have been eliminated. Certain information and footnote disclosures normally included in annual financial statements have been condensed or omitted. The Company believes the disclosures made are adequate to prevent the information presented from being misleading. However, the accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included within the Company’s Annual Report
on Form 10-K for the fiscal year ended March 31, 2026 (the “Annual Report”).
The unaudited condensed consolidated interim financial statements reflect all adjustments, consisting only of normal and recurring items, necessary to present fairly our financial position as of September 30, 2026, the results of operations and comprehensive loss, our cash flows, and changes in stockholders’ deficit, as of and for three and six months ended September 30, 2026 and 2025. Interim results are not necessarily indicative of full year performance because of short-term variations.
The condensed consolidated balance sheet at March 31, 2026 was derived from audited financial statements for the year ended March 31, 2026 included in the Annual Report but does not contain all of the footnote disclosures from the annual financial statements.
Reclassifications
Certain prior-period amounts in the condensed consolidated statements of cash flows have been reclassified to conform to the current period presentation. These reclassifications had no effect on total cash flows.
We have aggregated Manufacturing and Service Inventory into a single line called Inventories on the Condensed Consolidated Balance Sheets and we have aggregated Accrued Restructuring into Accrued Compensation. Details of the balances in the Inventories line item have been included in
Note 3 : Balance Sheet Information
and Accrued Restructuring has been included in
Note 6 : Restructuring Charges.
Liquidity
These condensed consolidated financial statements have been prepared in accordance with GAAP assuming the Company will continue as a going concern. The going concern assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business.
The Company generated cash flows from operations of approximately $
14.3
million for the six months ended September 30, 2026. The Company has historically funded operations through the sale of common stock and term debt borrowings in
Note 4: Debt
and
Note 7: Common Stock.
Management believes that it has the ability to obtain additional debt or equity financing, if required, and has historically been able to do so. In the first half of fiscal year 2027, the Company has generated positive operating cash flows and management believes that expected operating cash flows will be sufficient to fund operations for at least one year from the condensed consolidated financial statements issuance date.
11
Table of Contents
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ from these estimates and assumptions due to risks and uncertainties. Such estimates include, but are not limited to, the determination of standalone selling price for revenue arrangements with multiple performance obligations, inventory adjustments, useful lives of intangible assets and property and equipment, stock-based compensation, fair value of warrants, fair value of the Convertible Note and provision for income taxes including related reserves. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Restricted Cash
Restricted cash is comprised of bank guarantees and similar required minimum balances that serve as cash collateral in connection with various items including value added taxes, ongoing tax audits and leases in certain countries.
Accounts Receivable and Allowance for Credit Losses
Accounts receivable are recorded at the invoiced amount, and stated at realizable value, net of an allowance for credit losses. The Company maintains an allowance for credit losses for estimated losses based on historical experience and expected collectability of outstanding accounts receivable. The Company performs ongoing credit evaluations of its customers’ financial condition, and for the majority of its customers require no collateral. For customers that do not meet the Company’s credit standards, the Company may require a form of collateral, such as cash deposits or letters of credit, prior to the completion of a transaction. These credit evaluations require significant judgment and are based on multiple sources of information. The Company analyzes such factors as its historical bad debt experience, industry and geographic concentrations of credit risk, current economic trends and changes in customer payment terms. The Company will write-off customer balances in full to the reserve when it has determined that the balance is not recoverable. Changes in the allowance for credit losses are recorded in general and administrative expenses.
The Company has applied the practical expedient, where current conditions that do not affect the historical loss information are taken into account when determining the expected credit loss.
Warrant Accounting
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance Accounting Standards Codification ("ASC") Topic 480
, Distinguishing Liabilities from Equity
(“Topic 480”) and ASC Topic 815,
Derivatives and Hedging
(“Topic 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to Topic 480, meet the definition of a liability pursuant to Topic 480, and whether the warrants meet all of the requirements for equity classification under Topic 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance or modification. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statements of operations and comprehensive loss. Quantum issued a Conversion Warrant in June 2026 and Forbearance Warrant in September 2025.
See
Note 4: Debt
and
Note 11: Fair Value of Financial Instruments,
for further details.
Accounting Pronouncements Recently Adopted
In July 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurements of Credit Losses for Accounts
12
Table of Contents
Receivable and Contract Assets. ASU 2025-05 was effective for the Company beginning on April 1, 2026, and did not have a material impact on our financial statement disclosures.
Recent Accounting Pronouncements Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03,
Income Statement - Reporting Comprehensive Income -Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses
, which requires additional disclosures of specific expense categories included within each expense caption presented on the Statements of Operations. The new standard can be applied on either a fully retrospective or prospective basis. ASU 2024-03 will be effective for our fiscal year beginning April 1, 2027, and interim periods within our fiscal year beginning April 1, 2028, with early adoption permitted. The Company is currently evaluating the impact of this new standard on its financial statement disclosure.
In September 2025, the FASB issued ASU 2025-06,
Targeted Improvements to the Accounting for Internal-Use Software” (Topic 350)
. The updates eliminate references to software development project stages and revises the criteria that must be met to begin capitalizing internal-use software costs. The standard permits entities to adopt the guidance using a prospective, retrospective, or modified transition approach and becomes effective for the Company beginning April 1, 2028, with early adoption permitted. The Company is currently assessing the potential impact that ASU 2025-06 will have on its financial statement disclosures.
In December 2025, the FASB issued ASU 2025-11,
Interim Reporting (Topic 270): Narrow-Scope Improvements
, which clarifies certain aspects of interim reporting guidance. The standard is effective for interim periods within fiscal years beginning after December 15, 2027, which will be the Company’s fiscal year beginning April 1, 2028, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its interim financial statement disclosures.
In December 2025, the FASB issued ASU 2025-12, Codification Improvements, which amends a broad range of Topics to clarify guidance, correct errors, and make other improvements. The update clarifies that, when an entity reports a loss from continuing operations, it must consider whether instruments that may be settled in cash or shares and are classified as assets or liabilities are dilutive, including the related adjustments to the diluted net loss per share calculation, rather than presuming them to be antidilutive. The amendments to ASC 260 must be applied retrospectively to all periods presented. ASU 2025-12 will be effective for our fiscal year beginning April 1, 2027, including interim periods within that fiscal year, with early adoption permitted. The Company is currently evaluating the impact of this new standard, including the effect on diluted net loss per share related to its liability-classified warrants.
NOTE 2:
REVENUE
Contract Balances
The following table presents the Company’s contract assets and liabilities:
September 30, 2026
March 31, 2026
March 31, 2025
Accounts receivable, net
$
70,725
$
69,650
$
52,502
Contract assets - included in Other current assets
419
351
278
Deferred revenue, current portion
75,156
75,654
75,076
Deferred revenue, net of current portion
42,300
39,030
38,847
Remaining Performance Obligations
Total remaining performance obligations (“RPO”) refers to goods and services which have been contracted for but not recognized into revenue. RPO consists of both deferred revenue, which is included in the condensed consolidated balance sheets, and non-cancelable amounts from contracts that will be invoiced in the future. As of September 30, 2026, the total balance was $
184.6
million. This amount excludes variable consideration related to sales-based royalties.
13
Table of Contents
Remaining performance obligations consisted of the following (in thousands):
Current
Non-Current
Total
As of September 30, 2026
$
142,321
$
42,300
$
184,621
Deferred revenue primarily consists of amounts invoiced and paid but not recognized as revenue, including performance obligations pertaining to subscription services.
The table below reflects our deferred revenue as of September 30, 2026 (in thousands):
Deferred revenue as of September 30, 2026
Current
Non-current
Total
Service revenue
$
61,524
$
32,139
$
93,663
Subscription revenue
12,480
10,161
22,641
Product revenue
1,152
—
1,152
Total
$
75,156
$
42,300
$
117,456
The Company recognized revenue of $
42.6
million in the six months ended September 30, 2026 and $
48.1
million in the six months ended September 30, 2025 that was included in the contract liability balances at March 31, 2026 and 2025, respectively.
NOTE 3:
BALANCE SHEET INFORMATION
Certain significant amounts included in the Company's condensed consolidated balance sheets consist of the following (in thousands):
Inventories, net
September 30, 2026
March 31, 2026
Manufactured finished goods
$
9,111
$
5,887
Work in progress
848
990
Raw materials
11,948
8,508
Service parts
—
718
Total inventories
$
21,907
$
16,103
Goodwill
As of September 30, 2026 and March 31, 2026, goodwill was $
13.0
million. There were
no
impairments to goodwill as of September 30, 2026 and March 31, 2026.
Other Long-term Assets
September 30, 2026
March 31, 2026
Capitalized SaaS implementation costs for internal use
$
11,179
$
12,063
Deferred taxes
1,062
1,062
Contract cost asset
870
994
Other
225
618
Total other long-term assets
$
13,336
$
14,737
14
Table of Contents
Other current liabilities
September 30, 2026
March 31, 2026
Accrued expenses
$
6,585
$
7,456
Accrued interest
—
2,827
Accrued supplier owned inventory obsolescence
4,247
2,057
Accrued income taxes
1,489
1,153
Accrued warranty
1,003
772
Lease liability
881
799
Accrued product returns
720
783
Other
3,726
3,610
Total other current liabilities
$
18,651
$
19,457
The following table details the change in the Accrued warranty balance for each period presented (in thousands):
Six Months Ended September 30,
2026
2025
Beginning balance
$
772
$
1,032
Current period accruals
1,212
1,383
Adjustments to prior estimates
236
(
21
)
Charges incurred
(
1,069
)
(
1,653
)
Less amount presented in Other long-term liabilities
(
148
)
—
Ending balance
$
1,003
$
741
NOTE 4:
DEBT
The following table summarizes the Company's borrowing as of the dates presented (in thousands):
September 30, 2026
March 31, 2026
Term loan
$
—
$
55,906
Convertible Note
—
90,034
Less: current portion
—
(
54,811
)
Less unamortized debt issuance costs
(1)
—
(
1,095
)
Long-term debt, net
$
—
$
90,034
(1)
The unamortized debt issuance costs related to the Term Loan are presented as a reduction of the carrying amount of the corresponding debt balance on the accompanying condensed consolidated balance sheet as of March 31, 2026.
Prior to June 2026, the Company’s debt consisted of (i) senior secured term loans (the “Term Loan”) under its Term Loan Credit and Security Agreement, dated August 5, 2021, as amended (the “Term Loan Credit Agreement”), and (ii) a
10.00
% PIK Senior Secured Convertible Note due 2028 (the “Convertible Note”) issued on December 18, 2025 to Dialectic Technology SPV, LLC (“Dialectic”) in exchange for the Term Loans held by Dialectic. The Company elected the fair value option under ASC 825 for the Convertible Note. In connection with the Fifteenth Amendment to the Term Loan Credit Agreement, entered into on September 23, 2025 (the “Fifteenth Amendment”), the Company issued Dialectic a warrant to purchase up to
2,653,308
shares of its common stock (the “Forbearance Warrant”). For a description of the terms of, and amendments to, these instruments, see the notes to the audited consolidated financial statements included in the Annual Report.
On June 1, 2026, the Company entered into a Sixteenth Amendment to the Term Loan Credit Agreement to facilitate the Private Placement (as defined in
Note 7 : Common Stock
) and the Conversion (as defined below).
Pursuant to a Conversion Agreement dated June 1, 2026 (the “Conversion Agreement”), on June 4, 2026, Dialectic, as the sole beneficial owner of the Convertible Note, voluntarily converted the entire principal amount of the
15
Table of Contents
Convertible Note, together with all accrued and unpaid interest thereon, which was approximately $
57.2
million, into shares of the Company’s common stock (the “Conversion”), and the Convertible Note was canceled.
As consideration for the Conversion, the Company (i) amended the Convertible Note to waive certain notice and settlement requirements otherwise applicable to a voluntary exchange; (ii) issued to Dialectic
3.1
million additional shares of the Company’s common stock, representing the present value of PIK interest that would have accrued on the Convertible Note through its stated maturity plus the Term Loan deferred cash interest owed to Dialectic, divided by the $
5.1940
conversion price; and (iii) issued to Dialectic the Conversion Warrant (as defined in
Note 7 : Common Stock)
. See
Note 7 : Common Stock
for additional information.
On June 4, 2026, the Company paid an aggregate of $
57.8
million in connection with the termination of the Term Loan Credit Agreement, consisting of the entire outstanding principal amount, accrued interest, and fees and expenses incurred in connection with the termination. The Company recorded a loss on debt extinguishment of $
11.7
million associated with this transaction.
On June 4, 2026 and pursuant to the terms of the Conversion Agreement, the Convertible Note was canceled, and the Indenture was satisfied and discharged in full. See
Note 11: Fair Value of Financial Instruments
for full details of the transaction.
Related Party Transactions
The Forbearance Warrant, Conversion Warrant and Convertible Note issued to Dialectic constitute related party transactions, as John Fichthorn, a member of the Company's board of directors, is also Managing Partner of Dialectic Capital Management, the investment adviser to Dialectic. The fair values of the Forbearance Warrant and Conversion Warrant as of September 30, 2026 are included in
Note 11: Fair Value of Financial Instruments
. The Convertible Note was canceled on June 4, 2026 when the indenture governing the Convertible Note was satisfied and discharged in full.
NOTE 5:
LEASES
Supplemental condensed consolidated balance sheets information related to leases is as follows (in thousands):
Operating leases
September 30, 2026
March 31, 2026
Operating lease right-of-use assets
$
7,075
$
7,416
Operating lease liability, current - included in other current liabilities
$
881
$
799
Operating lease liability
7,799
8,172
Total operating lease liabilities
$
8,680
$
8,971
The components of lease expense were as follows (in thousands):
Three Months Ended September 30,
Six Months Ended September 30,
Lease expense
2026
2025
2026
2025
Operating lease expense
$
527
$
472
$
1,067
$
1,141
Variable lease expense
30
36
63
75
Short-term lease expense
109
113
217
188
Total lease expense
$
666
$
621
$
1,347
$
1,404
16
Table of Contents
Maturity of Lease Liabilities
Operating Leases
Remainder of fiscal year 2027
$
992
2028
1,638
2029
1,257
2030
1,241
2031
1,285
Thereafter
9,569
Total lease payments
15,982
Less: Imputed interest
(
7,302
)
Present value of lease liabilities
$
8,680
Lease Term and Discount Rate
September 30, 2026
March 31, 2026
Weighted average remaining operating lease term (years)
9.9
10.2
Weighted average discount rate for operating leases
12.69
%
12.67
%
Operating cash outflows related to operating leases totaled $
1.1
million and $
1.1
million for the six months ended September 30, 2026 and 2025, respectively.
NOTE 6:
RESTRUCTURING CHARGES
During the six months ended September 30, 2026, the Company continued to carry out existing restructuring plans to rationalize its cost structure. All restructuring activities from prior years were completed by the fourth quarter of fiscal 2026. During fiscal year 2026, all employees were notified; however, due to local requirements, not all employees had left employment by the end of the fiscal year.
The following tables show the activity for accrued restructuring (in thousands):
Severance and
benefits
Balance as of March 31, 2025
$
786
Restructuring charges
5,616
Cash payments
(
5,599
)
Other non-cash
52
Balance as of September 30, 2025
855
Balance as of March 31, 2026
566
Restructuring charges
315
Cash payments
(
854
)
Other non-cash
2
Balance as of September 30, 2026
$
29
NOTE 7:
COMMON STOCK
Stock Options
During the six months ended September 30, 2026, the Company granted options to purchase shares of the Company's common stock as follows:
1,508,650
options on April 1, 2026,
20,000
options on August 1, 2026, and
80,000
options on September 1, 2026. The stock options were valued using the Black-Scholes option pricing model on the grant date. There were
no
options granted during the three or six months ended September 30, 2025.
17
Table of Contents
The significant assumptions used by the Company to estimate the fair value of the option awards are summarized below:
Grant Date
Term (years)
Volatility
1
Dividend yield
2
Risk-free interest rate
3
Weighted-average grant date fair value
April 1, 2026
7.00
years
99.9
%
0.00
%
4.02
%
$
3.94
August 1, 2026
7.00
years
102.8
%
0.00
%
4.49
%
$
8.50
September 1, 2026
7.00
years
105.5
%
0.00
%
4.58
%
$
19.58
1
Volatility is based off of the Company's historical stock price over a period of the expected term of the options.
2
Dividend yield is set to
0.00
% as the Company has not historically paid dividends.
3
Risk-free interest rate is based on the Treasury yield for the expected term of the options.
Stock-based Compensation Expense
The following table details the Company's stock-based compensation expense (in thousands):
Three Months Ended September 30,
Six Months Ended September 30,
2026
2025
2026
2025
Cost of revenue
$
27
$
41
$
34
$
(
567
)
Research and development
(
57
)
19
43
87
Sales and marketing
185
(
82
)
323
(
6
)
General and administrative
680
346
1,183
281
Total stock-based compensation
$
835
$
324
$
1,583
$
(
205
)
Three Months Ended September 30,
Six Months Ended September 30,
2026
2025
2026
2025
Restricted stock units
$
327
$
544
$
664
$
239
Performance share units
46
(
220
)
33
(
444
)
Stock options
462
—
886
—
Total stock-based compensation
$
835
$
324
$
1,583
$
(
205
)
Private Placement
On June 1, 2026, the Company entered into Securities Purchase Agreements with certain accredited investors, pursuant to which the Company, in a private placement (the “Private Placement”), agreed to issue and sell to the investors an aggregate of
10,615,712
shares of the Company’s common stock, par value $
0.01
per share, at a price of $
9.42
per share, for aggregate gross proceeds to the Company of $
100.0
million. After deducting placement agent fees and other offering expenses payable by the Company, the Company received net proceeds of approximately $
94.3
million. The Private Placement closed June 4, 2026.
Standby Equity Purchase Agreement
On January 25, 2025, the Company entered into the SEPA with YA II PN, Ltd., a Cayman Islands exempt limited partnership ("YA") in which pursuant to which the Company had the right, but not the obligation, to sell up to $
200.0
million of its common stock to YA.
On June 4, 2026, in accordance with the terms of the SEPA, the Company provided a notice to YA regarding its termination of the SEPA, effective June 11, 2026. There were no amounts owed to YA under the SEPA at the time the termination notice was provided.
The Company did not make any sales under the SEPA during fiscal 2027, prior to termination. Comparatively, the Company had sales of
6.32
million shares for net proceeds of approximately $
67
million in the first half of fiscal 2026.
NOTE 8:
NET LOSS PER SHARE
Equity Instruments Outstanding
18
Table of Contents
The Company has stock options, warrants, performance share units and restricted stock units granted under various stock incentive plans that, upon exercise and vesting, would increase shares outstanding.
The dilutive impact related to shares of common stock from incentive plans and outstanding warrants is determined by applying the treasury stock method to the assumed vesting of outstanding performance share units and restricted stock units and the exercise of outstanding options and warrants. The dilutive impact related to shares of common stock from contingently issuable performance share units is determined by applying a two-step approach using both the contingently issuable share guidance and the treasury stock method.
The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (in thousands):
Three Months Ended September 30,
Six Months Ended September 30,
2026
2025
2026
2025
Stock awards
1
1,128
104
743
91
Warrants
1,475
—
870
—
Total
2,603
104
1,613
91
1
Stock awards include stock options, performance share units and restricted stock units
As of September 30, 2026, there were
13,909
shares of common stock equivalents related to performance-based stock options that vest only upon the achievement of specified performance conditions and the completion of a time-based service period. These contingently issuable options were excluded from the computation of diluted net loss per share for the three and six months ended September 30, 2026, and from the table above, as the specified performance conditions were not met as of September 30, 2026.
The Company had outstanding performance share units subject to market or performance conditions as of September 30, 2026 and 2025 that were eligible to vest into shares of common stock subject to the achievement of certain stock price or financial targets in addition to a time-based vesting period. These contingently issuable shares are excluded from the computation of diluted net loss per share if, based on current period results, the shares would not be issuable if the end of the reporting period were the end of the contingency period. There were
2,956
and
34,201
shares of contingently issuable performance share units subject to market or performance conditions that were excluded from the table above as the conditions were not satisfied as of September 30, 2026 and 2025, respectively.
NOTE 9:
INCOME TAXES
The effective tax rate for the three and six months ended September 30, 2026 was (
0.3
)% and (
0.4
)%, respectively, as compared to (
0.4
)% and (
0.6
)% for the three and six months ended September 30, 2025, respectively. The effective tax rates differed from the federal statutory tax rate of 21% during each of these periods due primarily to unbenefited losses experienced in jurisdictions with valuation allowances on deferred tax assets as well as the forecasted mix of earnings in domestic and international jurisdictions.
As of September 30, 2026, including interest and penalties, the Company had $
78.7
million of unrecognized tax benefits, $
69.5
million of which, if recognized, would favorably affect the effective tax rate without consideration of the valuation allowance. As of September 30, 2026, the Company had accrued interest and penalties related to these unrecognized tax benefits of $
1.3
million. The Company recognizes interest and penalties related to income tax matters in the income tax provision in the condensed consolidated statements of operations and comprehensive loss. As of September 30, 2026, $
71.6
million of unrecognized tax benefits were recorded as a contra deferred tax asset in other long-term assets in the condensed consolidated balance sheets and $
7.1
million (including interest and penalties) was recorded in other long-term liabilities in the condensed consolidated balance sheets. During the next 12 months, it is reasonably possible that approximately $
1.8
million of tax benefits, inclusive of interest and penalties, that are currently unrecognized could be recognized as a result of the expiration of applicable statutes of limitations. Upon recognition of the tax benefit related to the expiring statutes of limitations, $
0.8
million will be offset by the establishment of a related valuation allowance. The net tax benefit recognized in the condensed consolidated statements of operations and comprehensive loss is estimated to be $
1.0
million.
NOTE 10:
COMMITMENTS AND CONTINGENCIES
19
Table of Contents
Commitments to Purchase Inventory
The Company uses contract manufacturers for its manufacturing operations. Under these arrangements, the contract manufacturer procures inventory to manufacture products based upon its forecast of customer demand. The Company has similar arrangements with certain other suppliers. The Company is responsible for the financial impact on the supplier or contract manufacturer of any reduction or product mix shift in the forecast relative to materials that the third party had already purchased under a prior forecast. Such a variance in forecasted demand could require a cash payment for inventory in excess of current customer demand or for costs of excess or obsolete inventory. As of September 30, 2026, the Company had issued non-cancelable commitments for $
245.9
million to purchase inventory from its contract manufacturers and suppliers.
Legal Proceedings
From time to time, we are a party to various legal proceedings and claims arising from the normal course of business activities. Based on current available information, we do not expect that the ultimate outcome of any additional currently pending unresolved matters, individually or in the aggregate, will have a material adverse effect on our results of operations, cash flows or financial position.
Litigation
Shareholder Litigation
On September 4, 2025, a shareholder class action complaint was filed in the United States District Court for the District of Colorado. The complaint identifies Seung Lee as the plaintiff and names Quantum Corporation and James J. Lerner, Kenneth P. Gianella, and Laura Nash as defendants. It alleges certain violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 related to certain disclosures made in the Company’s quarterly and annual reports regarding its financial reporting for the third quarter of the Company’s fiscal year 2025 and its restatement of that financial reporting. The complaint sought to designate the plaintiff as the lead plaintiff for the class and define a class period of November 15, 2024 through August 18, 2025. On January 27, 2026, a revised final complaint named Hunsu Son as the lead plaintiff and reiterated the violations alleged in the original complaint. The revised complaint seeks an award of unspecified damages, costs, and expenses. The Company has filed a motion to dismiss the litigation, which has not yet been heard. The litigation is currently in its early stages and no discovery has taken place. As a result, the case has not progressed enough to support an opinion on potential outcomes or the possibility that damages could be awarded. Consequently, at this time, Quantum is not able to determine whether this lawsuit would have any material adverse effect on our business, operating results, or financial condition.
Derivative Litigation
On October 28, 2025, a shareholder derivative complaint was filed in the United States District Court for the District of Colorado. The complaint was filed by Brent Cullison derivatively on behalf of Quantum Corporation against James J. Lerner, Kenneth P. Gianella, Laura Nash, Don Jaworski, John Fichthorn, Hugues Meyrath, John R. Tracy, Emily White, James C. Clancy, and Tony J. Blevins. The complaint substantially repeats the allegations of the shareholder litigation described above and alleges related breaches of fiduciary duties and other causes of action. The complaint seeks recovery of damages sustained by Quantum arising from the allegations, as well as fees and costs incurred.
Another shareholder derivative complaint was filed in the same court on November 4, 2025. That complaint names Felicia Marti on behalf of Quantum Corporation as the plaintiff, with James J. Lerner, Kenneth P. Gianella, Laura Nash, John Fichthorn, Donald J. Jaworski, Hugues Meyrath, John R. Tracy, and Emily White named as defendants. The complaint substantially repeats the allegations of the Cullison derivative litigation and seeks relief of recovery of damages sustained by Quantum arising from the allegations, certain corporate governance reforms, and fees and costs incurred.
The court ordered the separate Cullison and Marti shareholder derivative complaints to be consolidated and stayed pending further activity in the shareholder class action litigation.
To date, no additional substantive activity has occurred. As a result, the case has not progressed enough to support an opinion on potential outcomes or the possibility that damages could be awarded. At this time, Quantum is not able to determine whether the consolidated lawsuits would have any material impact on our business, operating results, or financial condition.
20
Table of Contents
Leases
At September 30, 2026 and March 31, 2026, the Company had various non-cancelable operating leases for office facilities. Refer to
Note 5: Leases,
for additional information regarding lease commitments.
NOTE 11:
FAIR VALUE OF FINANCIAL INSTRUMENTS
The Company follows the guidance in ASC 820,
Fair Value Measurement,
for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The Company has certain non-financial assets that are measured at fair value on a non-recurring basis when there is an indicator of impairment, and they are recorded at fair value only when an impairment is recognized. These assets include property and equipment and amortizable intangible assets. The Company did not record impairments to any non-financial assets during the three and six months ended September 30, 2026 and 2025.
The carrying amounts reported in the accompanying condensed consolidated financial statements for cash and cash equivalents, restricted cash, accounts receivable, accounts payable and other current liabilities approximate their respective fair values because of the short-term nature of these accounts.
Debt
The fair value of the Company’s debt was estimated using a discounted cash flow approach based on the Company’s current borrowing rates for similar types of debt instruments, adjusted for credit and nonperformance risk. The Company uses significant other observable market data and assumptions (Level 2 inputs, as defined in ASC 820,
Fair Value Measurement
) that it believes market participants would use in pricing such debt.
The carrying value and estimated fair value of the Company’s debt were as follows (in thousands):
September 30, 2026
March 31, 2026
Carrying Value
Fair Value
Carrying Value
Fair Value
Term Loan
$
—
$
—
$
55,906
$
51,339
On June 4, 2026, the Company paid the entire outstanding principal amount and terminated the Term Loan Credit Agreement,
see Note 4 : Debt
for further details,
Warrants
Forbearance Warrant
On September 23, 2025, the Company established the initial fair value for the Forbearance Warrant issued to Dialectic in connection with the Fifteenth Amendment, which allows the purchase of up to
2,653,308
shares of Common Stock at an exercise price of $
8.81
. The fair value was subsequently remeasured as of September 30, 2026 and March 31, 2026, and the resulting changes in fair value were recognized in the condensed consolidated statements of operations and comprehensive loss under “Change in fair value of warrant liabilities”.
The Forbearance Warrant was valued using a Monte Carlo simulation model in conjunction with a Probability-Weighted Expected Return Model. This model incorporates various assumptions, including the Company’s common stock price, expected volatility, risk-free interest rate, and the remaining contractual term of the warrant.
Because the valuation relies on significant unobservable inputs, the fair value of the Forbearance Warrant is classified as Level 3 within the fair value hierarchy (as defined in ASC 820,
Fair Value Measurement
).
The following table summarizes the key assumptions used in estimating the fair value of the Forbearance Warrant at September 30, 2026 and March 31, 2026:
21
Table of Contents
September 30, 2026
March 31, 2026
Discount period (years)
5.98
years
6.48
years
Risk-free interest rate
4.49
% -
5.07
%
3.65
% -
4.02
%
Stock price volatility
110.00
%
100.00
%
Stock price at valuation date
$
31.72
$
4.75
Probability
1
10
% -
15
% -
75
%
15
% -
15
% -
70
%
Fair value (in thousands)
$
80,000
$
14,105
(1)
Scenario probability at March 31, 2026 was based on timing expectations of management that a liquidation event occurring was estimated at
15
%; a fundamental transaction occurring was estimated at
15
%; and none of the previous events were estimated at
70
%. Scenario probability at September 30, 2026 incorporated a
10
% of a liquidation event occurring; a
15
% of a fundamental transaction occurring; and none of the previous events were estimated at
75
%.
The table below sets forth a summary of changes in the fair value of the Company’s Forbearance Warrant liability for the three and six months ended September 30, 2026:
Balance at March 31, 2026
$
14,105
Change in fair value of forbearance warrant for the 3 months ended June 30, 2026
16,290
Balance at June 30, 2026
30,395
Change in fair value of forbearance warrant for the 3 months ended September 30, 2026
49,605
Balance at September 30, 2026
$
80,000
Conversion Warrant
On June 1, 2026, the Company issued to Dialectic a warrant (the “Conversion Warrant”) to purchase up to
105,911
shares of Common Stock at an exercise price of $
5.1940
. The Company established the initial fair value for the Conversion Warrant issued to Dialectic in connection with the Sixteenth Amendment. The fair value was subsequently remeasured as of September 30, 2026, and the resulting change in fair value was recognized in the condensed consolidated statement of operations and comprehensive loss under “Change in fair value of warrant liabilities.”
The Conversion Warrant was valued using a Monte Carlo simulation model in conjunction with a Probability-Weighted Expected Return Model. This model incorporates various assumptions, including the Company’s common stock price, expected volatility, risk-free interest rate, and the remaining contractual term of the warrant.
Because the valuation relies on significant unobservable inputs, the fair value of the Conversion Warrant is classified as Level 3 within the fair value hierarchy (as defined in ASC 820,
Fair Value Measurement
). Significant changes in the Company's stock price, volatility, or changes in the key assumptions stated below could result in a significantly higher or lower fair value of the warrant liabilities.
The following table summarizes the key assumptions used in estimating the fair value of the Conversion Warrant at issuance and at September 30, 2026:
September 30, 2026
June 1, 2026
Discount period (years)
4.67
years
5
years
Risk-free interest rate
4.49
% -
5.01
%
3.81
% -
4.14
%
Stock price volatility
110.00
%
100.00
%
Stock price at valuation date
$
31.72
$
10.49
Probability
1
10
% -
15
% -
75
%
10
% -
15
% -
75
%
Fair value (in thousands)
$
3,255
$
1,280
(1)
Scenario probability as of issuance and at September 30, 2026 was based on timing expectations of management that a liquidation event occurring was estimated at
10
%; a fundamental transaction occurring was estimated at
15
%; and none of the previous events were estimated at
75
%.
22
Table of Contents
The table below sets forth a summary of changes in the fair value of the Company’s Conversion Warrant liability for the three and six months ended September 30, 2026:
Balance at March 31, 2026
$
—
Issuance of Conversion Warrant
1,280
Change in fair value of Conversion Warrant for the 3 months ended June 30, 2026
15
Balance at June 30, 2026
1,295
Change in fair value of Conversion Warrant for the 3 months ended September 30, 2026
1,960
Balance at September 30, 2026
$
3,255
Convertible Note
On June 4, 2026 and pursuant to the terms of the Conversion Agreement, the Company’s outstanding Convertible Note was canceled, and the Indenture was satisfied and discharged in full. At the time of settlement, the Company issued to Dialectic
14,104,620
shares of common stock with an aggregate fair value of $
222.6
million, at a share price of $
15.78
. Of this amount, $
219.7
million represents the fair value of the Convertible Note prior to conversion, and $
2.8
million represents the deferred cash interest owed to Dialectic under the Term Loan Credit Agreement that was settled through the share issuance. The change in the fair value of the Convertible Note was recognized in the condensed consolidated statements of operations and comprehensive loss under “Change in fair value of Convertible Note”.
The table below sets forth a summary of changes in the fair value of the Company’s Convertible Note for the six months ended September 30, 2026:
Balance at March 31, 2026
$
90,034
Change in fair value of Convertible Note
129,715
Conversion of Convertible Note
(
219,749
)
Balance at September 30, 2026
$
—
NOTE 12:
SEGMENT INFORMATION
The Company operates as a single operating segment and a single reportable segment. The Company's chief operating decision maker ("CODM") is its Chief Executive Officer. The measure of segment profit or loss that the CODM uses to allocate resources and assess performance is net income (loss). The CODM uses net income (loss) to make resource allocation decisions, evaluate budgets and forecasts, and assess the Company's overall performance, including monitoring budgeted versus actual results.
Disaggregation of Revenue
23
Table of Contents
The following table depicts the disaggregation of revenue by geographic areas and major product offerings and geographies and is consistent with how the Company evaluates its financial performance (in thousands):
Three Months Ended September 30,
Six Months Ended September 30,
2026
2025
2026
2025
Americas
1
Product revenue
$
33,783
$
20,937
$
58,055
$
43,689
Service and subscription
14,249
14,988
27,704
29,347
Total revenue
48,032
54
%
35,925
57
%
85,759
50
%
73,036
58
%
EMEA
Product revenue
19,638
10,849
39,139
20,832
Service and subscription
8,480
8,423
17,178
16,905
Total revenue
28,118
31
%
19,272
31
%
56,317
33
%
37,737
30
%
APAC
Product revenue
9,163
3,582
19,262
8,384
Service and subscription
2,282
2,209
4,798
4,311
Total revenue
11,445
13
%
5,791
9
%
24,060
14
%
12,695
10
%
Consolidated
Product revenue
62,584
35,368
116,456
72,905
Service and subscription
25,011
25,620
49,680
50,563
Royalty
2
2,030
2
%
1,727
3
%
4,293
3
%
3,534
3
%
Total revenue
$
89,625
100
%
$
62,715
100
%
$
170,429
100
%
$
127,002
100
%
1
Revenue for Americas geographic region outside of the United States is not significant.
2
Royalty revenue is not allocable to geographic regions.
Revenue by Solution
Three Months Ended September 30,
Six Months Ended September 30,
2026
%
2025
%
2026
%
2025
%
Primary storage systems
$
7,994
9
%
$
10,968
17
%
$
16,482
9
%
$
23,497
18
%
Secondary storage systems
44,741
50
%
19,778
32
%
81,773
48
%
38,285
30
%
Device and media
11,565
13
%
7,550
12
%
21,926
13
%
17,492
14
%
Service
23,295
26
%
22,692
36
%
45,955
27
%
44,194
35
%
Royalty
2,030
2
%
1,727
3
%
4,293
3
%
3,534
3
%
Total revenue
1
$
89,625
100
%
$
62,715
100
%
$
170,429
100
%
$
127,002
100
%
1
Subscription revenue of $
3.7
million and $
6.4
million was allocated to Primary and Secondary storage systems for the six months ended September 30, 2026 and 2025, respectively. Subscription revenue of $
1.7
million and $
2.9
million was allocated to primary and secondary storage systems for the three months ended September 30, 2026 and 2025, respectively.
Net Loss
The following table shows reported segment revenue, segment profit or loss, and significant segment expenses were as follows (in thousands):
24
Table of Contents
Three Months Ended September 30,
Six Months Ended September 30,
2026
2025
2026
2025
Total revenue
$
89,625
$
62,715
$
170,429
$
127,002
Total cost of revenue
52,899
39,163
101,983
80,736
Gross profit
36,726
23,552
68,446
46,266
Gross margin
41.0
%
37.6
%
40.2
%
36.4
%
Operating expenses
Salaries & fringe
1
17,356
16,731
33,099
34,733
Outside services
2
5,684
4,763
10,029
12,439
Infrastructure
3
1,941
2,330
3,777
4,852
Operational costs
4
2,264
2,060
4,582
4,392
Restructuring
292
3,193
315
5,616
Other operating expenses
5
2,409
2,633
4,826
4,987
Total operating expenses
29,946
31,710
56,628
67,019
Income (Loss) from operations
6,780
(
8,158
)
11,818
(
20,753
)
Other income (expense), net
80
(
185
)
292
(
616
)
Interest expense
—
(
6,227
)
(
2,097
)
(
12,743
)
Change in fair value of warrant liabilities
(
51,565
)
1,525
(
67,870
)
1,525
Change in fair value of Convertible Note
—
—
(
129,715
)
—
Loss on debt extinguishment
—
(
33,254
)
(
11,716
)
(
30,695
)
Loss before income taxes
(
44,705
)
(
46,299
)
(
199,288
)
(
63,282
)
Income tax provision
145
157
855
380
Net loss
$
(
44,850
)
$
(
46,456
)
$
(
200,143
)
$
(
63,662
)
1
Salaries & fringe includes spend on contractors.
2
Outside services includes contractor, recruiting and legal expenses.
3
Infrastructure includes property related expenses, including fixed and variable lease expense, telecommunications and depreciation.
4
Operational costs include dues and subscriptions, computer expenses, office supplies and other miscellaneous items.
5
Other operating expenses includes travel related spend, marketing expense, taxes, fees and other miscellaneous items.
25
Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis compares our results of operations for the three and six months ended September 30, 2026 and September 30, 2025, and should be read together with the condensed consolidated financial statements and the related notes included in this Quarterly Report on Form 10-Q, and with the audited consolidated financial statements and related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2026 (the “Annual Report”). In particular, the risk factors contained in Part I, Item 1A of the Annual Report under the heading “Risk Factors” may reflect trends, demands, commitments, events, or uncertainties that could materially affect our results of operations, liquidity, and capital resources. For comparisons of the three and six months ended September 30, 2025 and 2024, see our Management's Discussion and Analysis of Financial Condition and Results of Operations in Item 2 of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, filed with the SEC on November 13, 2025 and incorporated herein by reference. Our fiscal year ends on March 31. "Fiscal 2026" refers to the fiscal year ended March 31, 2026. In the tables below, "n/m" indicates a percentage change that is not meaningful.
The following discussion contains forward-looking statements, such as statements regarding anticipated impacts on our business, our future operating results and financial position, our business strategy and plans, our market growth and trends, and our objectives for future operations. Please see "Note Regarding Forward-Looking Statements" for more information about relying on these forward-looking statements.
Overview and Highlights
We are a technology company whose mission is to deliver innovative solutions to forward-thinking organizations across the world. We design, manufacture and sell technology and services that help customers capture, create and share digital content, and protect it for decades. We emphasize innovative technology in the design and manufacture of our products to help our customers unlock the value in their video and unstructured data in new ways to solve their most pressing business challenges.
We generate revenue by designing, manufacturing, and selling technology and services. Our most significant expenses are related to compensating employees; designing, manufacturing, marketing, and selling our products and services; data center costs in support of our cloud-based services; and income taxes.
Macroeconomic Conditions
We continue to actively monitor, evaluate and respond to the current uncertain macro environment, including the impact of changing interest rates, inflation, tariffs, lingering supply chain challenges, and fluctuation in the U.S. dollar. During the quarter we continued to experience longer sales cycles for opportunities with our enterprise as well as commercial customers.
The macro environment remains unpredictable and our past results may not be indicative of future performance.
26
Table of Contents
RESULTS OF OPERATIONS
Three Months Ended September 30,
Six Months Ended September 30,
(in thousands)
2026
2025
2026
2025
Total revenue
$
89,625
$
62,715
$
170,429
$
127,002
Total cost of revenue
(1)
52,899
39,163
101,983
80,736
Gross profit
36,726
23,552
68,446
46,266
Operating expenses
Sales and marketing
(1)
12,168
11,819
23,196
24,474
General and administrative
(1)
11,126
11,006
20,734
24,576
Research and development
(1)
6,360
5,692
12,383
12,353
Restructuring charges
292
3,193
315
5,616
Total operating expenses
29,946
31,710
56,628
67,019
Income (Loss) from operations
6,780
(8,158)
11,818
(20,753)
Other income (expense), net
80
(185)
292
(616)
Interest expense
—
(6,227)
(2,097)
(12,743)
Change in fair value of warrant liabilities
(51,565)
1,525
(67,870)
1,525
Change in fair value of convertible note
—
—
(129,715)
—
Loss on debt extinguishment, net
—
(33,254)
(11,716)
(30,695)
Loss before income taxes
(44,705)
(46,299)
(199,288)
(63,282)
Income tax provision
145
157
855
380
Net income (loss)
$
(44,850)
$
(46,456)
$
(200,143)
0
$
(63,662)
(1)
Includes stock-based compensation as follows:
Three Months Ended September 30,
Six Months Ended September 30,
(in thousands)
2026
2025
2026
2025
Cost of revenue
$
27
$
41
$
34
$
(567)
Research and development
(57)
19
43
87
Sales and marketing
185
(82)
323
(6)
General and administrative
680
346
1,183
281
Total
$
835
$
324
$
1,583
$
(205)
27
Table of Contents
Comparison of the Three Months Ended September 30, 2026 and 2025
Revenue
Three Months Ended September 30,
(in thousands)
2026
% of
revenue
2025
% of
revenue
$ Change
% Change
Product revenue
$
62,584
70
%
$
35,368
56
%
$
27,216
77
%
Service and subscription revenue
25,011
28
%
25,620
41
%
(609)
(2)
%
Royalty revenue
2,030
2
%
1,727
3
%
303
18
%
Total revenue
$
89,625
100
%
$
62,715
100
%
$
26,910
43
%
Product Revenue
In the three months ended September 30, 2026, product revenue increased $27.2 million, or 77%, as compared to the same period in fiscal 2026. The primary driver of this increase was strong demand across all secondary storage product lines including Scalar tape storage products, ActiveScale object storage appliances, and DXi backup appliances. Overall, secondary storage revenue increased by $25.0 million, or 126.2% as compared to the same period in fiscal 2026. Devices and media revenues also increased by $4.0 million, or 53.2% as compared to fiscal 2026. These increases were partially offset by declines in primary storage.
Service and Subscription Revenue
Service and subscription revenue remained flat with a small decrease of $0.6 million, or 2%, in the three months ended September 30, 2026, compared to the same period in fiscal 2026.
Royalty Revenue
We receive royalties from third parties that license our linear-tape open media patents through our membership in the linear-tape open consortium. Royalty revenue increased $0.3 million, or 18%, in the three months ended September 30, 2026, as compared to the same period in fiscal 2026, related to higher overall unit shipments.
Gross Profit and Margin
Three Months Ended September 30,
(in thousands)
2026
Gross
margin %
2025
Gross
margin %
$ Change
Basis point change
Product gross profit
$
20,447
32.7
%
$
6,620
18.7
%
$
13,827
1,400
Service and subscription gross profit
14,249
57.0
%
15,205
59.3
%
(956)
(230)
Royalty gross profit
2,030
100.0
%
1,727
100.0
%
303
—
Gross profit
$
36,726
41.0
%
$
23,552
37.6
%
$
13,174
340
Gross profit and margin percentages are key metrics that management monitors to assess the performance on the business.
Product Gross Margin
Product gross margin increased by 1,400 basis points for the three months ended September 30, 2026, as compared to fiscal 2026. Majority of the increase is tied to higher volume of core products with better blended margin mix and increased average selling prices, and benefit from proactively managing our supply chain ahead of supplier price increases.
Service and Subscription Gross Margin
Service and subscription gross margin remained flat with a small decrease of 230 basis points for the three months ended September 30, 2026, as compared to fiscal 2026.
Royalty Gross Margin
Royalties do not have significant related cost of sales.
28
Table of Contents
Operating Expenses
Three Months Ended September 30,
(in thousands)
2026
% of
revenue
2025
% of
revenue
$ Change
% Change
Sales and marketing
$
12,168
14
%
$
11,819
19
%
$
349
3
%
General and administrative
11,126
12
%
11,006
18
%
120
1
%
Research and development
6,360
7
%
5,692
9
%
668
12
%
Restructuring charges
292
—
%
3,193
5
%
(2,901)
(91)
%
Total operating expenses
$
29,946
33
%
$
31,710
51
%
$
(1,764)
(6)
%
In the three months ended September 30, 2026, sales and marketing expenses increased $0.3 million, or 3%, as compared with fiscal 2026. This increase was primarily driven by variable expense due to growth in revenue compared to fiscal 2026.
In the three months ended September 30, 2026, general and administrative expenses increased $0.1 million, or 1%, as compared with fiscal 2026, and remained relatively flat due to continued administrative efficiencies.
In the three months ended September 30, 2026, research and development expenses increased $0.7 million, or 12%, as compared with fiscal 2026. This increase was the result of strategic investment into our product development teams.
In the three months ended September 30, 2026, restructuring charges decreased $2.9 million, or 91%, as compared with fiscal 2026. The decrease is due to the corporate restructuring activities being largely complete.
Other Expense, net
Three Months Ended September 30,
(in thousands)
2026
% of
revenue
2025
% of
revenue
$ Change
% Change
Other income (expense), net
$
80
0
%
$
(185)
0
%
$
265
n/m
In the three months ended September 30, 2026, the change in other income (expense) resulted in a net increase of $0.3 million compared to fiscal 2026. The increase was primarily related to an increase in interest received partially offset by movements in foreign currency gains and losses during each period.
Interest expense
Three Months Ended September 30,
(in thousands)
2026
% of
revenue
2025
% of
revenue
$ Change
% Change
Interest expense
$
—
—
%
$
(6,227)
(10)
%
6,227
(100)
%
In the three months ended September 30, 2026, interest expense decreased by $6.2 million, or 100%, as compared to fiscal 2026. This decrease was primarily due to the repayment of our Term Loan (as defined herein) in June 2026. The Company had no outstanding debt during the three months ended September 30, 2026.
Warrant liabilities
Three Months Ended September 30,
(in thousands)
2026
% of
revenue
2025
% of
revenue
$ Change
% Change
Change in fair value of warrant liabilities
$
(51,565)
(58)
%
$
1,525
2
%
$
(53,090)
n/m
29
Table of Contents
In the three months ended September 30, 2026, we recorded a non-cash loss of $51.6 million related to the change in fair value of our forbearance warrant which was issued in September 2025 and conversion warrant which was issued in June 2026. The loss was primarily driven by fluctuations in our stock price.
(Loss) gain on debt extinguishment, net
Three Months Ended September 30,
(in thousands)
2026
% of
revenue
2025
% of
revenue
$ Change
% Change
Gain (loss) on debt extinguishment, net
$
—
—
%
$
(33,254)
(53)
%
$
33,254
(100)
%
In the three months ended September 30, 2026, we recorded no gain (loss) on debt extinguishment. In the three months ended September 30, 2025, we recorded a loss on debt extinguishment due to termination of the PNC Credit Facility as well as the amendments to the Term Loan during the quarter.
Income Tax Provision
Three Months Ended September 30,
(in thousands)
2026
% of pretax income
2025
% of pretax income
$ Change
% Change
Income tax provision
$
145
(0.3)
%
$
157
(0.4)
%
$
(12)
(7.6)
%
Income tax provision for the three months ended September 30, 2026 and 2025 is primarily influenced by foreign and state income taxes.
Due to our history of net losses in the United States, the protracted period for utilizing tax attributes uncertain foreign jurisdictions, and the difficulty in predicting future results, we believe that we cannot rely on projections of future taxable income to realize most of our deferred tax assets. Accordingly, we have established a full valuation allowance against our U.S. and certain foreign net deferred tax assets. Significant management judgment is required in assessing our ability to realize any future benefit from our net deferred tax assets. We intend to maintain this valuation allowance until sufficient positive evidence exists to support its reversal. Our income tax expense recorded in the future will be reduced to the extent that sufficient positive evidence materializes to support a reversal of, or decrease in, our valuation allowance.
Comparison of the Six Months Ended September 30, 2026 and 2025
Revenue
Six Months Ended September 30,
(dollars in thousands)
2026
% of
revenue
2025
% of
revenue
$ Change
% Change
Product revenue
$
116,456
68
%
$
72,905
57
%
$
43,551
60
%
Service and subscription
49,680
29
%
50,563
40
%
(883)
(2)
%
Royalty
4,293
3
%
3,534
3
%
759
21
%
Total revenue
$
170,429
100
%
$
127,002
100
%
$
43,427
34
%
Product Revenue
In the six months ended September 30, 2026, product revenue increased $43.6 million, or 60%, as compared to the same period in fiscal 2026. The primary driver of the increase was strong demand across all secondary storage product lines including Scalar tape storage products, ActiveScale object storage appliances, and DXi backup appliances. Overall, secondary storage revenue increased by $43.5 million, or 114% as compared to the same period in fiscal 2026. Devices and media revenues also increased by $4.4 million, or 25% as compared to fiscal 2026. These increases were partially offset by declines in primary storage.
30
Table of Contents
Service and Subscription Revenue
Service and subscription revenue decreased $0.9 million, or 2%, in the six months ended September 30, 2026 compared to the same period in fiscal 2026. This decrease was due to certain end of life products reaching their end-of-service-life.
Royalty Revenue
We receive royalties from third parties that license our linear-tape open media patents through our membership in the linear-tape open consortium. Royalty revenue saw an increase of $0.8 million, or 21%, in the six months ended September 30, 2026 compared to the same period in fiscal 2026 related to higher overall unit shipments.
Gross Profit and Margin
Six Months Ended September 30,
(dollars in thousands)
2026
Gross
margin %
2025
Gross
margin %
$ Change
Basis point change
Product
$
34,595
29.7
%
$
13,412
18.4
%
$
21,183
1,130
Service and subscription
29,558
59.5
%
29,320
58.0
%
238
150
Royalty
4,293
100.0
%
3,534
100.0
%
759
—
Gross profit
$
68,446
40.2
%
$
46,266
36.4
%
$
22,180
380
Gross profit and margin percentages are key metrics that management monitors to assess the performance on the business.
Product Gross Margin
Product gross margin increased by $21.2 million, or by 1,130 basis points, for the six months ended September 30, 2026, as compared with the same period in fiscal 2026. Majority of the increase is tied to higher volume of core products with better blended margin mix and increased average selling prices, and benefit from proactively managing our supply chain ahead of supplier price increases.
Service and Subscription Gross Margin
Service and subscription gross margins increased 150 basis points for the six months ended September 30, 2026, as compared with the same period in fiscal 2026. This improvement was primarily driven by reduced service of end of life products. There is also focus on service cost reduction across the organization, including logistics, repair, and labor.
Royalty Gross Margin
Royalties do not have significant related cost of sales.
Operating Expenses
Six Months Ended September 30,
(dollars in thousands)
2026
% of revenue
2025
% of revenue
$ Change
% Change
Sales and marketing
$
23,196
14
%
$
24,474
19
%
$
(1,278)
(5)
%
General and administrative
20,734
12
%
24,576
19
%
(3,842)
(16)
%
Research and development
12,383
7
%
12,353
10
%
30
—
%
Restructuring charges
315
—
%
5,616
4
%
(5,301)
(94)
%
Total operating expenses
$
56,628
33
%
$
67,019
53
%
$
(10,391)
(16)
%
In the six months ended September 30, 2026, sales and marketing expenses decreased $1.3 million, or 5%, as compared with the same period in fiscal 2026. This decrease was primarily driven by improved operational efficiency and increased leverage of our channel.
In the six months ended September 30, 2026, general and administrative expenses decreased $3.8 million, or 16%, as compared with the same period in fiscal 2026. This decrease was primarily driven by higher expense in the prior year related to compliance focused outside services.
31
Table of Contents
In the six months ended September 30, 2026, research and development expenses increased $0.03 million, or 0.2%, as compared with the same period in fiscal 2026. This effectively flat trend was driven by efficiency gains realized in prior periods, partially offset by strategic investments in our product development teams.
In the six months ended September 30, 2026, restructuring expenses decreased $5.3 million, or 94% as compared with the same period in fiscal 2026. The decrease is due to the corporate restructuring activities being largely complete.
Other Income (Expense), net
Six Months Ended September 30,
(dollars in thousands)
2026
% of revenue
2025
% of revenue
$ Change
% Change
Other income (expense), net
$
292
—
%
$
(616)
—
%
$
908
147
%
The change in other income (expense), net during the six months ended September 30, 2026 compared with the same period in fiscal 2026 was related to increase in interest income partially offset by fluctuations in foreign currency exchange rates during the six months ended September 30, 2026.
Interest Expense
Six Months Ended September 30,
(dollars in thousands)
2026
% of revenue
2025
% of revenue
$ Change
% Change
Interest expense
$
(2,097)
(1)
%
$
(12,743)
(10)
%
$
10,646
(84)
%
In the six months ended September 30, 2026, interest expense decreased $10.6 million, or 84%, as compared with the same period in fiscal 2026 due to the repayment of the Term Loan in June 2026.
Warrant Liabilities
Six Months Ended September 30,
(dollars in thousands)
2026
% of revenue
2025
% of revenue
$ Change
% Change
Change in fair value of warrant liabilities
$
(67,870)
(40)
%
$
1,525
1
%
$
(69,395)
n/m
In the six months ended September 30, 2026, we recorded a combined non-cash loss of $67.9 million related to the change in fair value of our forbearance and conversion warrant liabilities. In the six months ended September 30, 2025, we recorded a non-cash gain of $1.5 million.
Loss on Debt Extinguishment
Six Months Ended September 30,
(dollars in thousands)
2026
% of revenue
2025
% of revenue
$ Change
% Change
Loss on debt extinguishment
$
(11,716)
(7)
%
$
(30,695)
(24)
%
$
18,979
(62)
%
In the six months September 30, 2026, we recorded a loss of $11.7 million on debt extinguishment, primarily related to the repayment of our Term Loan in June 2026. In the six months ended September 30, 2025, the loss on debt extinguishment relates to the transfer of the long-term debt to a new lender and the subsequent amendments which occurred during the first and second fiscal quarters.
32
Table of Contents
Income Taxes
Six Months Ended September 30,
(dollars in thousands)
2026
% of pretax income
2025
% of pretax income
$ Change
% Change
Income tax provision
$
855
—
%
$
380
(1)
%
$
475
125
%
The income tax provision for the six months ended September 30, 2026 and 2025 is primarily influenced by foreign and state income taxes. Due to our history of net losses in the United States, the protracted period for utilizing tax attributes in certain foreign jurisdictions, and the difficulty in predicting future results, we believe that we cannot rely on projections of future taxable income to realize most of our deferred tax assets. Accordingly, we have established a full valuation allowance against our U.S. and certain foreign net deferred tax assets. Significant management judgment is required in assessing our ability to realize any future benefit from our net deferred tax assets. We intend to maintain this valuation allowance until sufficient positive evidence exists to support its reversal. Our income tax expense recorded in the future will be reduced to the extent that sufficient positive evidence materializes to support a reversal of, or decrease in, our valuation allowance.
Liquidity and Capital Resources
We consider liquidity in terms of the sufficiency of internal and external cash resources to fund our operating, investing and financing activities. Our principal sources of liquidity include cash from operating activities, cash and cash equivalents on our balance sheet and proceeds from the sale of common stock. We require significant cash resources to provide for our research and development activities, fund our working capital needs, and make capital expenditures. Our future liquidity requirements will depend on multiple factors, including our research and development plans and capital investment needs. We believe our existing cash and cash equivalents and cash flows from operations will be sufficient to fund our operations, working capital and capital expenditure needs for at least the next 12 months.
We had cash and cash equivalents of $67.4 million as of September 30, 2026, which excludes $0.1 million of short-term restricted cash. Our total outstanding Term Loan debt was fully repaid in the first quarter of fiscal 2027.
We generated cash flows from operations of approximately $14.3 million for the six months ended September 30, 2026, compared to negative cash flows of $32.5 million for the six months ended September 30, 2025. We generated net losses of approximately $200.1 million and $63.7 million for the six months ended September 30, 2026 and 2025, respectively. We have funded operations through the sale of common stock and debt borrowings as described in
Note 4: Debt
and
Note 7 : Common Stock.
Cash Flows
The following table summarizes our consolidated cash flows for the periods indicated.
Six Months Ended September 30,
(in thousands)
2026
2025
Cash provided by (used in):
Operating activities
$
14,316
$
(32,489)
Investing activities
(643)
(1,606)
Financing activities
37,588
32,791
Effect of exchange rate changes
—
30
Net change in cash, cash equivalents, and restricted cash
$
51,261
$
(1,274)
Net Cash Provided By (Used In) Operating Activities
Net cash provided by operating activities was $14.3 million for the six months ended September 30, 2026, compared to net cash used of $32.5 million for the six months ended September 30, 2025, an improvement of $46.8
33
Table of Contents
million. The improvement was primarily driven by improved operating results, lower cash interest paid following the repayment of the Term Loan in June 2026, and favorable changes in deferred revenue and accounts payable.
Net Cash Used in Investing Activities
Net cash used in investing activities was $0.6 million and $1.6 million for the six months ended September 30, 2026 and 2025, respectively, consisting of capital expenditures.
Net Cash Provided by Financing Activities
Net cash provided by financing activities was $37.6 million for the six months ended September 30, 2026, primarily due to $94.3 million of net Private Placement proceeds, partially offset by $56.8 million of Term Loan repayments. Net cash provided by financing activities of $32.8 million for the six months ended September 30, 2025 was primarily due to $67.0 million of SEPA proceeds, partially offset by net debt repayments.
Commitments and Contingencies
Our contingent liabilities consist primarily of certain financial guarantees, both express and implied, related to product liability and potential infringement of intellectual property. We have little history of costs associated with such indemnification requirements and contingent liabilities associated with product liability may be mitigated by our insurance coverage. In the normal course of business to facilitate transactions of our services and products, we indemnify certain parties with respect to certain matters, such as intellectual property infringement or other claims. We also have indemnification agreements with our current and former officers and directors. It is not possible to determine the maximum potential amount under these indemnification agreements due to the limited history of our indemnification claims, and the unique facts and circumstances involved in each particular agreement. Historically, payments made by us under these agreements have not had a material impact on our operating results, financial position or cash flows.
We are also subject to ordinary course of business litigation, See
Note 10: Commitments and Contingencies
, to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.
CRITICAL ACCOUNTING ESTIMATES AND POLICIES
The preparation of our condensed consolidated financial statements in accordance with GAAP requires management to make judgments, estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes included elsewhere in this Quarterly Report. On an ongoing basis, we evaluate estimates, which are based on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. We consider certain accounting policies to be critical to understanding our financial statements because the application of these policies requires significant judgment on the part of management, which could have a material impact on our financial statements if actual performance should differ from historical experience or if our assumptions were to change. Our accounting policies that include estimates that require management’s subjective or complex judgments about the effects of matters that are inherently uncertain are summarized in the Annual Report under the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates and Policies”. Other than the elimination of the fair value of the Convertible Note as a critical accounting estimate following its conversion on June 4, 2026, and the inclusion of the Conversion Warrant, issued on June 1, 2026, within our estimate of the fair value of warrant liabilities, there have been no material changes to our critical accounting estimates and policies during the six months ended September 30, 2026 from those disclosed in the Annual Report. For additional information on our significant accounting policies, see Note 1 to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.
Recently Issued and Adopted Accounting Pronouncements
For recently issued and adopted accounting pronouncements, see
Note 1: Description of Business and Significant Accounting Policies
, to our condensed consolidated financial statements.
34
Table of Contents
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes to our quantitative and qualitative disclosures about market risk from those described under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Annual Report, which such section is incorporated herein by reference.
ITEM 4. CONTROLS AND PROCEDURES
Limitations on Effectiveness of Controls and Procedures
In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Principal Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report. Based on this evaluation, our Chief Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were not effective due to material weaknesses in internal control over financial reporting related to revenue recognition, inventories, income taxes and control environment as previously described in Part II, Item 9A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2026, which remain unremediated as of September 30, 2026.
Notwithstanding the identified material weaknesses, management, including our Chief Executive Officer and Principal Financial Officer, have determined, based on the procedures performed, that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q fairly present in all material respects the financial condition, results of operations and cash flows of the Company for the periods presented in accordance with U.S. generally accepted accounting principles.
Remediation Update
Management has initiated and continues to implement a remediation plan designed to address the material weaknesses described above. Remediation activities in the quarter ended September 30, 2026 include:
•
Engaging an independent third-party consulting firm with expertise in internal controls over financial reporting, revenue recognition, inventory accounting, and Sarbanes-Oxley compliance to assist management in evaluating control deficiencies, designing enhanced controls, and supporting remediation efforts;
•
We continued to implement enhanced controls over sales order entry, contract review, deferral schedule maintenance, and standalone selling price analyses to support compliance with ASC 606;
•
We enhanced inventory count, reconciliation, and monitoring procedures, including enhanced controls over the reconciliation of physical inventory records to underlying system records;
•
We began implementing enhanced controls over the preparation and review of the income tax provision and related tax accounts and disclosures by implementing a formalized preparation and review process.
•
We enhanced the accounting and finance organization through the addition of personnel with public company financial reporting, revenue recognition, inventory accounting, and income tax expertise. During the second quarter, we hired a Director of Tax and a Chief Accounting Officer who is a certified public accountant with prior public company financial reporting experience.
While management has begun implementing these remediation measures, the material weaknesses cannot be considered remediated until the enhanced controls have been fully designed, implemented, operated for a sufficient period of time, and management has completed testing and concluded that the controls are operating effectively.
Changes in Internal Controls over Financial Reporting
Except for the matters discussed above, there were no changes in our internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our
35
Table of Contents
internal control performed during the fiscal quarter ended September 30, 2026, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
36
Table of Contents
PART II
ITEM 1. LEGAL PROCEEDINGS
From time to time, we are involved in legal proceedings and claims arising in the ordinary course of business. See
Note 10: Commitments and Contingencies
to the unaudited condensed consolidated financial statements for a discussion of our legal matters.
ITEM 1A. RISK FACTORS
There have been no material changes to the previously disclosed risk factors discussed in “Part I, Item 1A, Risk Factors” in the Annual Report. You should consider carefully these factors, together with all of the other information in this Quarterly Report, including our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report, before making an investment decision.
ITEM 5.
OTHER INFORMATION
On
September 10, 2026
,
Yue-Zhou (Emily) White
, a
member of the Company’s board of directors
,
adopted
a trading plan intended to satisfy Rule 10b5-1(c) under the Exchange Act with respect to the sale of up to
4,440
shares of common stock between December 10, 2026 and
March 31, 2027
.
On
September 10, 2026
,
John R. Tracy
, a
member of the Company’s board of directors
,
adopted
a trading plan intended to satisfy Rule 10b5-1(c) under the Exchange Act with respect to the sale of up to
4,440
shares of common stock between December 10, 2026 and
March 31, 2027
.
Both trading plans above were enacted to satisfy vesting-related tax obligations.
ITEM 6. EXHIBITS
The exhibits required to be filed or furnished as part of this Quarterly Report are listed below. Notwithstanding any language to the contrary, exhibits 32.1 and 32.2 shall not be deemed to be filed as part of this Quarterly Report for purposes of Section 18 of the Exchange Act or deemed to be incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, except to the extent that the Company specifically incorporates it by reference.
Incorporated by Reference
Exhibit
Number
Exhibit Description
Form
Filing Date
Exhibit
Filed or Furnished Herewith
3.1
Amended and Restated Certificate of Incorporation of the Company, as amended through August 26, 2024
S-1
01/27/25
3.1
3.2
Amended and Restated Bylaws of the Company, as amended through June 12, 2025
8-K
06/18/25
3.1
10.1#
Offer Letter
dated
August 6
, 2026
by and
between
the Company and
Hiral A. Patel
.
8-K
09/01/26
10.1
10.2#
Quantum Corporation 2023 Long-Term Incentive Plan, as amended and restated through July 21, 2026.
S-8
09/25/26
99.1
10.3#
Offer Letter dated September 24, 2026 by and between the Company and James C. Clancy.
8-K
09/28/26
10.1
31.1
Certification of the Principal Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
X
31.2
Certification of the Principal Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
X
32.1
Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002
X
32.2
Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002
X
101.INS
XBRL Instance Document
X
37
Table of Contents
Incorporated by Reference
Exhibit
Number
Exhibit Description
Form
Filing Date
Exhibit
Filed or Furnished Herewith
101.SCH
XBRL Taxonomy Extension Schema Document
X
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
X
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
X
101.LAB
XBRL Taxonomy Extension Label Linkbase Document
X
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
X
104
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
X
* Schedules and attachments have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant hereby undertakes to furnish supplemental copies of any of the omitted schedules and attachments upon request by the Securities and Exchange Commission.
38
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Quantum Corporation
(Registrant)
November 9, 2026
/s/ Hugues Meyrath
(Date)
Hugues Meyrath
President and Chief Executive Officer
(Principal Executive Officer)
November 9, 2026
/s/ Hiral A. Patel
(Date)
Hiral A. Patel
Principal Financial Officer and Chief Accounting Officer
39